run_id,metamodule,annotation,folder,run_index,program_index,program_name,description,supporting_genes,supporting_gene_count,significance_score,predicted_impacts
00_Gliosis_run1,0,Gliosis,00_Gliosis,1,0,Mesenchymal Transition & Invasion,"This program encompasses the transition of glioblastoma cells towards a mesenchymal, highly invasive state associated with aggressive tumor progression, therapy resistance, and poor prognosis. Gene products facilitate ECM remodeling, motility, and intratumoral heterogeneity.","[""FN1"", ""COL6A2"", ""COL1A2"", ""COL5A1"", ""TNC"", ""SPP1"", ""SERPINE1"", ""CHI3L1"", ""FOSL1"", ""BIRC3"", ""MET"", ""AXL"", ""CAV1"", ""HMGA2""]",14,0.97,"[""Enhanced invasion and motility of tumor cells"", ""Promotion of therapy resistance by supporting stem-like populations"", ""ECM remodeling and increased intratumoral heterogeneity""]"
00_Gliosis_run1,0,Gliosis,00_Gliosis,1,1,Hypoxia Response & Angiogenesis,"Genes driving responses to hypoxia, neovascularization, and metabolic adaptation. Prominent in glioblastoma's enhancement of vascular networks, therapeutic resistance, and resilience in low-oxygen microenvironments.","[""VEGFA"", ""ANGPTL4"", ""APLN"", ""CCN1"", ""ICAM1"", ""SERPINE1"", ""NDRG1"", ""BIRC3"", ""MET"", ""ANPEP""]",10,0.95,"[""Induction of angiogenesis and microvascular proliferation"", ""Cellular adaptation to hypoxia and metabolic stress"", ""Promotion of inflammation and immune cell recruitment""]"
00_Gliosis_run1,0,Gliosis,00_Gliosis,1,2,Immunosuppression & Inflammation,"Genes promoting immune evasion, immunosuppressive microenvironment via cytokines, chemokines, immune checkpoints, and inflammation mediators.","[""IL6"", ""CXCL10"", ""CXCL8"", ""IL1R1"", ""PTGS2"", ""TLR2"", ""ICAM1"", ""CD274"", ""IDO1"", ""FAS"", ""BIRC3"", ""TNFAIP3"", ""SAA1"", ""SAA2"", ""SAA4"", ""CXCL14""]",16,0.93,"[""Inhibition of anti-tumor immunity"", ""Recruitment of immunosuppressive macrophages and T cells"", ""Promotion of chronic inflammation tissue remodeling""]"
00_Gliosis_run1,0,Gliosis,00_Gliosis,1,3,Stem Cell Maintenance & Therapy Resistance,"Genes regulating maintenance, self-renewal, and therapy resistance of glioblastoma stem-like cells, driving tumor initiation, recurrence, and resistance to cytotoxic treatment.","[""PROM1"", ""LIF"", ""HMGA2"", ""FOSL1"", ""MET"", ""BIRC3"", ""SERPINE1""]",7,0.92,"[""Promotion of tumor initiation and recurrence"", ""Resistance to cytotoxic and antiangiogenic treatments"", ""Enhanced stem cell maintenance and plasticity""]"
00_Gliosis_run2,0,Gliosis,00_Gliosis,2,0,Mesenchymal Transition & Invasion,"This program assembles genes regulating key drivers of mesenchymal transition, cellular motility, matrix remodeling, tumor infiltration, and invasion through both transcriptional reprogramming and effector proteins. FOSL1/AP-1, CHI3L1, SPP1, SERPINE1, CAV1, MET, AXL, FN1, COL5A1, and COL6A2 are prominent in driving or supporting mesenchymal phenotype and cellular invasion processes in glioblastoma.","[""FOSL1"", ""CHI3L1"", ""SERPINE1"", ""SPP1"", ""FN1"", ""CAV1"", ""MET"", ""AXL"", ""COL1A2"", ""COL5A1"", ""COL6A2""]",11,0.98,"[""promotes mesenchymal shift and invasion"", ""enhances cell migration and ECM degradation"", ""supports CAF-like microenvironment""]"
00_Gliosis_run2,0,Gliosis,00_Gliosis,2,1,Immune Modulation and Inflammation,"Cluster of genes representing cytokine/chemokine signaling, inflammatory response, and immune evasion mechanisms. Includes proinflammatory cytokines (IL6, IL1R1), acute phase reactants (SAA1/2/4), chemokines (CXCL8, CXCL10, CXCL14), and immune regulatory checkpoints (CD274), emphasizing the immunosuppressive and inflammatory tumor microenvironment in GBM.","[""IL6"", ""IL1R1"", ""SAA1"", ""SAA2"", ""SAA4"", ""CXCL8"", ""CXCL10"", ""CXCL14"", ""IDO1"", ""CD274""]",10,0.93,"[""drives immunosuppressive microenvironment"", ""sustains chronic inflammation and paracrine tumor support"", ""facilitates immune escape""]"
00_Gliosis_run2,0,Gliosis,00_Gliosis,2,2,Stemness and Therapy Resistance,"Genes maintaining glioblastoma stem-like cell (GSC) identity, pluripotency, and resistance to therapy, such as PROM1 (CD133), HMGA2, LIF, and BAG3. Markers here also impact tumor recurrence, plasticity, and response to stress.","[""PROM1"", ""HMGA2"", ""LIF"", ""BAG3""]",4,0.91,"[""supports GSC identity and heterogeneity"", ""maintains tumor-initiating potential and recurrence risk"", ""drives resistance to therapies""]"
00_Gliosis_run2,0,Gliosis,00_Gliosis,2,3,Angiogenesis & Hypoxic Response,"Groups angiogenic regulators (VEGFA, ANGPTL4, APLN, MET, COL1A2), hypoxia response elements (NDRG1, PTX3), and matrix modifiers, controlling vascular niche formation and metabolic adaptation.","[""VEGFA"", ""ANGPTL4"", ""APLN"", ""MET"", ""PTX3"", ""NDRG1""]",6,0.92,"[""promotes neovascularization"", ""supports metabolic adaptation to hypoxia"", ""enhances tumor growth and survival""]"
00_Gliosis_run2,0,Gliosis,00_Gliosis,2,4,Therapy Resistance and Drug Efflux,"Genes related to apoptosis suppression (BIRC3, TNFAIP3/2), multidrug resistance (ABCC3), and survival pathways. Program involves resistance to cell stress, apoptosis, and ineffective drug penetration.","[""BIRC3"", ""TNFAIP3"", ""TNFAIP2"", ""ABCC3""]",4,0.87,"[""increases resistance to chemotherapy"", ""suppresses apoptosis"", ""enhances tumor survival""]"
01_OPC-AC-like_1_run1,1,OPC-AC-like 1,01_OPC-AC-like_1,1,0,Glial/astrocyte differentiation and tumor plasticity,"Gene products such as GFAP mark astrocytic differentiation; in glioblastoma, heterogeneous expression patterns reflect diverse tumor cell populations and dedifferentiation. ARC and DAB1 participate in neural activity and cell signaling, potentially linked to malignant plasticity.","[""GFAP"", ""DAB1"", ""ARC""]",3,0.95,"[""astrocyte signature retention and dedifferentiation dynamics"", ""heterogeneous cellular phenotypes reflecting tumor adaptability""]"
01_OPC-AC-like_1_run1,1,OPC-AC-like 1,01_OPC-AC-like_1,1,1,Mesenchymal invasion and matrix remodeling,CD44 and ITGB4 coordinate cell-matrix adhesion and trafficking; ADAMTS5 and COL20A1 facilitate ECM degradation. GPC5 and PLA2G4A interface with the matrix and lipid metabolism to support invasion.,"[""CD44"", ""ITGB4"", ""ADAMTS5"", ""COL20A1"", ""PLA2G4A"", ""GPC5""]",6,0.93,"[""enhanced invasive capacity through ECM breakdown and increased motility"", ""tumor spread via matrix remodeling and pro-migratory signaling""]"
01_OPC-AC-like_1_run1,1,OPC-AC-like 1,01_OPC-AC-like_1,1,2,Redox and ferroptosis resistance,"SLC7A11/xCT mediates cystine uptake for glutathione synthesis, protecting tumor cells against oxidative stress and ferroptotic death. LUCAT1 and coordinated lncRNAs may further regulate stress response.","[""SLC7A11"", ""LUCAT1""]",2,0.9,"[""increased tumor resistance to ferroptosis and oxidative stress"", ""promotion of stem cell-like properties in hypoxic tumor regions""]"
01_OPC-AC-like_1_run1,1,OPC-AC-like 1,01_OPC-AC-like_1,1,3,Immune evasion: MHC class I downregulation,NLRC5 activates MHC class I transcription; its dysregulation in glioblastoma leads to reduced antigen presentation and impaired anti-tumor immunity.,"[""NLRC5""]",1,0.88,"[""dampened tumor immunogenicity and evasion of cytotoxic T cell response""]"
01_OPC-AC-like_1_run2,1,OPC-AC-like 1,01_OPC-AC-like_1,2,0,Mesenchymal Invasion and ECM Remodeling,"Co-activation of genes encoding ECM receptors and remodeling proteins (CD44, ITGB4, ADAMTS5, PLA2G4A, COL20A1, CHST8, XYLT1, GPC5, TNR) promote invasive, mesenchymal state and facilitate glioblastoma cell migration through the brain parenchyma. Many are upregulated in GBM with mesenchymal phenotype, linked to recurrent tumors and poor prognosis.","[""CD44"", ""ITGB4"", ""PLA2G4A"", ""ADAMTS5"", ""COL20A1"", ""CHST8"", ""XYLT1"", ""GPC5"", ""TNR""]",9,0.98,"[""Enhanced migratory capacity and brain infiltration"", ""Therapy resistance via ECM protection"", ""Recurrence after surgical resection""]"
01_OPC-AC-like_1_run2,1,OPC-AC-like 1,01_OPC-AC-like_1,2,1,"Cancer Stemness, Plasticity, and Therapy Resistance","Markers of stem cell phenotype (GFAP, CD44, SLC7A11, GPC5, LUCAT1, PPARGC1A) and key regulatory lncRNAs enable glioblastoma cells to maintain stem-like state, resist differentiation, and survive stressors including hypoxia and chemotherapy.","[""GFAP"", ""CD44"", ""SLC7A11"", ""GPC5"", ""LUCAT1"", ""PPARGC1A""]",6,0.95,"[""Maintains cell population capable of recurrence after therapy"", ""Resistance to chemoradiation"", ""Adaptation to hypoxic, nutrient-poor microenvironments""]"
01_OPC-AC-like_1_run2,1,OPC-AC-like 1,01_OPC-AC-like_1,2,2,Immune Evasion and Immune Microenvironment Interaction,"NLRC5, SLC7A11, and lncRNAs interact to modulate antigen presentation and redox state in glioblastoma, facilitating immune escape. Additional ECMâ€“related genes assist in constructing immunosuppressive niches.","[""NLRC5"", ""SLC7A11""]",2,0.9,"[""Evades T cell recognition"", ""Promotes redox homeostasis and resistance to immune cell mediated killing"", ""Maintains local immunosuppressive microenvironment""]"
01_OPC-AC-like_1_run2,1,OPC-AC-like 1,01_OPC-AC-like_1,2,3,Proliferation and Aberrant Cell Cycle Regulation,"PPARGC1A, KCNIP1, INPP4B, PLA2G4A, CD44, and specific lncRNAs (e.g., LUCAT1) coordinate metabolic and cell cycle programs to support high proliferative rates of glioblastoma cells.","[""PPARGC1A"", ""KCNIP1"", ""INPP4B"", ""PLA2G4A"", ""CD44"", ""LUCAT1""]",6,0.93,"[""Increased proliferation and metabolic flexibility"", ""Survival under nutrient and hypoxia stress"", ""Therapy resistance through metabolic adaptation""]"
01_OPC-AC-like_1_run2,1,OPC-AC-like 1,01_OPC-AC-like_1,2,4,Aberrant Neural and Synaptic Programs,"Genes encoding cell adhesion molecules, synaptic scaffolding proteins, and neural developmental regulators (UNC5D, LRRC4C, MDGA2, ARC, KCNIP1, ST8SIA1, ST8SIA5) are often upregulated in glioblastoma, supporting tumor-neuronal communication, invasion, and plasticity.","[""ARC"", ""MDGA2"", ""ST8SIA1"", ""ST8SIA5"", ""UNC5D""]",5,0.9,"[""Enhanced tumor\u2013neuron electrical coupling"", ""Network remodeling favoring tumor invasion"", ""Synaptic plasticity supporting proliferation and migration""]"
02_NPC-neuronal-like_1_run1,2,NPC-neuronal-like 1,02_NPC-neuronal-like_1,1,0,Motile Ciliary Axoneme,"This program represents a large cluster of genes encoding structural and regulatory components of motile cilia axonemes. The genes include multiple CFAP (cilia and flagella associated protein) family members (CFAP43, CFAP52, CFAP61, CFAP73, CFAP206, CFAP47, CFAP221, CFAP157, CFAP100), dynein arm proteins (DNAH12, DNAH5, DRC1, DNAAF1), radial spoke components (RSPH1), and axonemal assembly regulators (TTC29, TOGARAM2, LRRIQ1). These proteins collectively assemble and regulate the 9+2 microtubule structure characteristic of motile cilia. While motile cilia are not typically associated with differentiated glioblastoma cells, primary cilia play critical roles in glioma biology through Hedgehog signaling and other pathways. The aberrant expression of motile ciliary genes may reflect dedifferentiation, stem-like features, or ectopic developmental program activation in malignant glioblastoma.","[""CFAP43"", ""CFAP52"", ""CFAP61"", ""CFAP73"", ""CFAP206"", ""CFAP47"", ""CFAP221"", ""CFAP157"", ""CFAP100"", ""DNAH12"", ""DNAH5"", ""DRC1"", ""DNAAF1"", ""RSPH1"", ""TTC29"", ""LRRIQ1"", ""PKHD1"", ""DCDC2"", ""TOGARAM2""]",19,0.65,"[""Aberrant activation of ciliary developmental programs in dedifferentiated glioblastoma cells"", ""Potential modulation of Hedgehog and other cilium-dependent signaling pathways"", ""Reflects stem-like or progenitor cell features in malignant glioma cells""]"
02_NPC-neuronal-like_1_run1,2,NPC-neuronal-like 1,02_NPC-neuronal-like_1,1,1,Extracellular Matrix Remodeling,"This program encompasses genes encoding structural collagens (COL21A1, COL13A1, COL23A1, COL26A1), matricellular proteins (THBS1, POSTN), and basement membrane components (HMCN1). Thrombospondin-1 (THBS1) is particularly significant in glioblastoma, where it is upregulated at invasive tumor borders, promotes cell migration and invasion through CD47 interaction, and contributes to resistance to anti-angiogenic therapy. Periostin (POSTN) and collagen genes regulate the immunosuppressive tumor microenvironment and epithelial-mesenchymal transition. HMCN1, a fibulin family member and basement membrane component, is frequently mutated across cancers and may regulate tissue adhesion and invasion.","[""THBS1"", ""POSTN"", ""COL21A1"", ""COL13A1"", ""COL23A1"", ""COL26A1"", ""HMCN1""]",7,0.85,"[""Enhanced glioblastoma cell migration and invasion through ECM remodeling"", ""Establishment of immunosuppressive tumor microenvironment"", ""Promotion of mesenchymal phenotype and EMT in glioma cells"", ""Resistance to anti-angiogenic therapy mediated by THBS1""]"
02_NPC-neuronal-like_1_run1,2,NPC-neuronal-like 1,02_NPC-neuronal-like_1,1,2,GABAergic Neurotransmission,"This program includes GABA receptor subunits (GABRA5, GABRG3) and metabotropic glutamate receptors (GRM1, GRM4) that mediate inhibitory and excitatory neurotransmitter signaling. In glioblastoma, GABAergic signaling through GABA-A receptors can promote tumor growth through neuronal activity-dependent mechanisms. Glioma cells form functional neuron-glioma synapses and respond to GABAergic input, which can drive proliferation particularly in pediatric diffuse midline gliomas. GRM1 and GRM4 are part of neuroligin-3 and glutamate-mediated signaling that promotes glioma growth through neuronal activity.","[""GABRA5"", ""GABRG3"", ""GRM1"", ""GRM4"", ""KCNJ3""]",5,0.78,"[""Enhanced glioblastoma proliferation through neuronal activity-dependent GABAergic signaling"", ""Formation of functional neuron-glioma synapses"", ""Altered chloride homeostasis promoting depolarizing GABA responses"", ""Integration of neuronal microenvironment signals for tumor growth""]"
02_NPC-neuronal-like_1_run1,2,NPC-neuronal-like 1,02_NPC-neuronal-like_1,1,3,Transcriptional Regulation and Chromatin Remodeling,"This program includes zinc finger transcription factors (ZNF521, ZNF804B, PLAGL1), chromatin remodeling factors (CHD5, SATB1-AS1), and epigenetic regulators (PRMT8, AFF2). ZNF521 synergizes with GLI transcription factors to enhance Hedgehog signaling, which is critical in glioma stem cells. PLAGL1 is a core marker of glioblastoma that drives edge-to-core transition and directly regulates CD109 expression. CHD5 functions as a tumor suppressor in multiple cancers including gliomas. PRMT8 regulates neuronal differentiation and is depleted in glioblastoma. These genes collectively regulate stem cell programs, differentiation, and oncogenic transcription.","[""ZNF521"", ""PLAGL1"", ""CHD5"", ""PRMT8"", ""AFF2"", ""ZNF804B"", ""SATB1-AS1""]",7,0.82,"[""Enhanced Hedgehog signaling through ZNF521-GLI synergy in glioma stem cells"", ""Promotion of glioblastoma edge-to-core transition and CD109 expression by PLAGL1"", ""Loss of tumor suppressor function due to CHD5 downregulation"", ""Disrupted neuronal differentiation programs due to PRMT8 depletion""]"
02_NPC-neuronal-like_1_run1,2,NPC-neuronal-like 1,02_NPC-neuronal-like_1,1,4,cAMP Signaling and Kinase Cascades,"This program includes adenylate cyclase (ADCY8), kinase suppressor of RAS (KSR2), and MAP kinases (MAP3K19, MAP7) that regulate cAMP production and MAPK signaling. ADCY8 polymorphisms are sex-specific modifiers of glioma risk in neurofibromatosis type 1 patients. KSR2 regulates both ERK signaling and AMPK-dependent metabolism, and is essential for tumor cell energy homeostasis and anchorage-independent growth. The cAMP pathway regulates glioma proliferation, and its dysregulation contributes to tumorigenesis in a sexually dimorphic manner.","[""ADCY8"", ""KSR2"", ""MAP3K19"", ""MAP7""]",4,0.72,"[""Sex-specific modulation of glioma risk through ADCY8 polymorphisms"", ""Integration of mitogenic and metabolic signaling via KSR2"", ""Enhanced tumor cell proliferation and anchorage-independent growth"", ""Modulation of chemotherapy and radiation resistance through cAMP signaling""]"
02_NPC-neuronal-like_1_run1,2,NPC-neuronal-like 1,02_NPC-neuronal-like_1,1,5,Neuregulin-BMP Signaling,"This program includes neuregulin-3 (NRG3) and bone morphogenetic protein 6 (BMP6), which regulate neural development, stem cell differentiation, and tumor cell fate. NRG3 promotes glioma cell migration and invasion through enhanced L1CAM expression and is associated with immune cell infiltration. BMP signaling induces glioma stem cell quiescence and confers resistance to radiation and temozolomide by activating DNA repair machinery. The balance between TGF-beta and BMP signaling defines proliferative versus quiescent glioma stem cell states.","[""NRG3"", ""BMP6""]",2,0.76,"[""Enhanced glioma cell migration and invasion through NRG3-mediated L1CAM expression"", ""Establishment of quiescent, therapy-resistant glioma stem cell population via BMP signaling"", ""Modulation of tumor immune microenvironment by NRG3"", ""Increased DNA repair capacity and radiation resistance in BMP-activated cells""]"
02_NPC-neuronal-like_1_run1,2,NPC-neuronal-like 1,02_NPC-neuronal-like_1,1,6,Solute Carrier Transporters,"This program includes multiple solute carrier family members (SLC14A1, SLC47A2, SLC22A3) that transport urea, organic cations, and drugs across cell membranes. SLC47A1 (homolog of SLC47A2) is highly expressed in glioma stem cells and correlates with malignancy and poor prognosis. SLC22A3 expression is a favorable prognostic biomarker in glioblastoma. These transporters regulate drug uptake, metabolite transport, and may influence chemotherapy sensitivity and tumor metabolism.","[""SLC14A1"", ""SLC47A2"", ""SLC22A3""]",3,0.68,"[""Regulation of temozolomide sensitivity through drug transporter expression"", ""Modulation of metabolite homeostasis affecting glioma proliferation"", ""Influence on glioma stem cell sphere-forming ability"", ""Contribution to chemoresistance phenotypes""]"
02_NPC-neuronal-like_1_run1,2,NPC-neuronal-like 1,02_NPC-neuronal-like_1,1,7,Immune Cell Markers,"This program includes B-cell marker BANK1, immune adaptor FYB2, and interleukin-6 receptor (IL6R) that reflect immune cell infiltration in the glioblastoma microenvironment. B-cells in glioblastoma can drive response to immune checkpoint blockade, and their infiltration correlates with therapeutic efficacy. IL6R signaling is implicated in glioma progression and immune modulation. The presence of these immune markers may reflect lymphocyte infiltration or expression by tumor cells themselves.","[""BANK1"", ""FYB2"", ""IL6R""]",3,0.64,"[""Reflects B-cell and lymphocyte infiltration in glioblastoma microenvironment"", ""Potential modulation of immune checkpoint blockade response"", ""IL6-mediated tumor-immune cell interactions"", ""Formation of tertiary lymphoid structures in tumor""]"
02_NPC-neuronal-like_1_run2,2,NPC-neuronal-like 1,02_NPC-neuronal-like_1,2,0,Motile Cilia Function and Structure,"Cluster of genes (CFAP43, CFAP52, CFAP61, CFAP73, CFAP100, CFAP157, CFAP206, CFAP221, DNAH12, DNAH5, DRC1, DNAAF1, TCTEX1D1, DCDC2, RSPH1, LRRC2, LRRIQ1, TTC29, ZBBX, DTHD1) encode components of the motile cilium and its assembly machinery. In glioblastoma, aberrant ciliary function is increasingly recognized as contributing to tumor microenvironment interactions, signaling changes, and possibly immunosuppression.","[""CFAP43"", ""CFAP52"", ""CFAP61"", ""CFAP73"", ""CFAP100"", ""CFAP157"", ""CFAP206"", ""CFAP221"", ""DNAH12"", ""DNAH5"", ""DRC1"", ""DNAAF1"", ""TCTEX1D1"", ""DCDC2"", ""RSPH1"", ""LRRC2"", ""LRRIQ1"", ""TTC29"", ""ZBBX"", ""DTHD1""]",20,0.9,"[""Deficient or abnormal ciliary signaling may alter microenvironmental sensing and contribute to immune evasion in glioblastoma"", ""Disrupted ciliary assembly can impact cell division, Wnt signaling, and cell polarity""]"
02_NPC-neuronal-like_1_run2,2,NPC-neuronal-like 1,02_NPC-neuronal-like_1,2,1,Extracellular Matrix Remodeling and Tumor Invasion,"Multiple collagen and ECM-remodeling genes (COL21A1, COL13A1, COL23A1, COL26A1, THBS1, POSTN, HMCN1, ADAMTS18, CFAP-related) contribute to the composition, stiffness, and organization of the tumor microenvironment. Glioblastoma exploits these programs to facilitate invasion, angiogenesis, immune modulation, and therapy resistance.","[""COL21A1"", ""COL13A1"", ""COL23A1"", ""COL26A1"", ""THBS1"", ""POSTN"", ""HMCN1"", ""ADAMTS18""]",8,0.95,"[""Promotes tumor invasion through ECM stiffening and degradation"", ""Facilitates angiogenesis and immune exclusion"", ""Induces therapy resistance via physical barriers and signaling""]"
02_NPC-neuronal-like_1_run2,2,NPC-neuronal-like 1,02_NPC-neuronal-like_1,2,2,Inflammatory and Mesenchymal Signaling,"Genes IL6R, BMP6, POSTN, THBS1, SATB1-AS1, COL-related, and others act in canonical pathways that regulate inflammation, immune suppression, mesenchymal transition, and stemness in glioblastoma.","[""IL6R"", ""BMP6"", ""POSTN"", ""THBS1"", ""SATB1-AS1""]",5,0.97,"[""Drives immune suppression and poor therapy response"", ""Promotes stemness and invasion via mesenchymal transition"", ""Links inflammation to increased glioblastoma aggressiveness""]"
02_NPC-neuronal-like_1_run2,2,NPC-neuronal-like 1,02_NPC-neuronal-like_1,2,3,Neuronal and Synaptic Signaling Dysregulation,"Genes GABRA5, GABRG3, KCNJ3, GRM1, GRM4, NAALAD2, CA10, SLC22A3, SLC14A1, SLC47A2 are involved in neuro-signaling, glutamatergic, and GABAergic transmission, which are re-wired in glioblastoma to promote cell migration, invasion, and altered metabolism.","[""GRM1"", ""GRM4"", ""GABRA5"", ""GABRG3"", ""KCNJ3"", ""NAALAD2"", ""CA10"", ""SLC14A1"", ""SLC22A3"", ""SLC47A2""]",10,0.88,"[""Enhances tumor cell migration through neurotransmitter pathway hijacking"", ""Alters cell metabolism and microenvironment responsiveness""]"
02_NPC-neuronal-like_1_run2,2,NPC-neuronal-like 1,02_NPC-neuronal-like_1,2,4,Chromatin/Transcriptional Regulation and Tumor Suppressor Pathways,"Transcription factors and epigenetic regulators (CHD5, SATB1-AS1, ZNF521, ZNF804B, AFF2, PRMT8, RBMS3) coordinate gene expression programs, cell fate determination, and tumor suppression. In glioblastoma, loss or mutation in these genes drives therapy resistance, stemness, and cell state plasticity.","[""CHD5"", ""SATB1-AS1"", ""ZNF521"", ""ZNF804B"", ""AFF2"", ""PRMT8"", ""RBMS3""]",7,0.92,"[""Controls cell state plasticity and stemness"", ""Loss drives therapy resistance and tumor progression""]"
03_NPC-neuronal-like_2_run1,3,NPC-neuronal-like 2,03_NPC-neuronal-like_2,1,0,Extracellular Matrix Remodeling & Invasion,"Enrichment for genes encoding ECM proteins, ECM remodelers and their regulators associated with glioblastoma cell invasion, mesenchymal transition, and tumor angiogenesis. Programs include collagen (COL3A1, COL6A3), periostin (POSTN), TGFBI, FAP, SMOC2, and multiple matrix metalloproteinases (ADAMTS3). Periostin and FAP+ mesenchymal cells promote active angiogenesis, abnormal vascular structure, and stemness.","[""COL3A1"", ""COL6A3"", ""POSTN"", ""TGFBI"", ""FAP"", ""SMOC2"", ""ADAMTS3"", ""FRAS1""]",8,0.96,"[""Enhanced invasion through remodeling of matrix"", ""Promotion of abnormal angiogenesis and vascular niche formation"", ""Increased tumor cell migration""]"
03_NPC-neuronal-like_2_run1,3,NPC-neuronal-like 2,03_NPC-neuronal-like_2,1,1,Glutamatergic & Synaptic Signaling Deregulation,"Enrichment for vesicular glutamate transporters (SLC17A6), glutamate receptor components (GRIN2A), and synaptic proteins (SV2B, SYT1, RIMBP2). Tumors hijack glutamatergic synapses and signaling to promote invasion, hyperexcitability, and stem cell maintenance.","[""SLC17A6"", ""GRIN2A"", ""SV2B"", ""SYT1"", ""RPH3A"", ""RIMBP2""]",6,0.94,"[""Enhanced glutamatergic signaling drives tumor proliferation and invasion"", ""Tumor-induced hyperexcitability and epileptogenesis"", ""Aberrant synaptic connectivity fosters glioblastoma stem cell niche""]"
03_NPC-neuronal-like_2_run1,3,NPC-neuronal-like 2,03_NPC-neuronal-like_2,1,2,Axon Guidance & Cell Migration,"Collective enrichment for axon guidance proteins (EFNA5, SEMA3C, UNC5D, CNTN5, CNTNAP4), with roles in migration/invasion, tumor plasticity, and stem cell maintenance.","[""EFNA5"", ""SEMA3C"", ""UNC5D"", ""CNTN5"", ""CNTNAP4""]",5,0.91,"[""Facilitates invasion via re-purposing axon guidance programs"", ""Supports tumor cell plasticity, migration, and self-renewal""]"
03_NPC-neuronal-like_2_run1,3,NPC-neuronal-like 2,03_NPC-neuronal-like_2,1,3,Transcriptional & Epigenetic Reprogramming,"Enrichment for transcription factors (EBF1, EBF2, CUX2, MYT1L, POU6F2, RUNX1T1), RNA-binding proteins (RBFOX1), and splicing factors, which drive stemness, plasticity, and resistance. Links to aberrant splicing program.","[""EBF1"", ""EBF2"", ""CUX2"", ""MYT1L"", ""POU6F2"", ""RUNX1T1"", ""RBFOX1"", ""SRRM4""]",8,0.88,"[""High plasticity and drug resistance via transcriptional reprogramming"", ""Enhanced self-renewal and stemness""]"
03_NPC-neuronal-like_2_run1,3,NPC-neuronal-like 2,03_NPC-neuronal-like_2,1,4,Potassium Channel & Ion Transport Adaptations,"Several potassium channel (KCNJ6, KCNC2, DPP10) and ion transport modulators support cellular adaptation for migration, volume regulation, and therapy resistance.","[""KCNJ6"", ""KCNC2"", ""DPP10""]",3,0.85,"[""Enhanced migration and invasiveness"", ""Potential therapy resistance via cell volume regulation""]"
03_NPC-neuronal-like_2_run2,3,NPC-neuronal-like 2,03_NPC-neuronal-like_2,2,0,Extracellular Matrix and Invasion,"Collagen (COL3A1, COL6A3), periostin (POSTN), and fibroblast activation protein (FAP) contribute to the remodeling of the glioblastoma extracellular matrix, driving cell invasion, angiogenesis, and progression. These genes encode ECM proteins and regulators found upregulated in GBM and facilitate tumor cell migration, vessel formation, and therapeutic resistance.","[""COL3A1"", ""COL6A3"", ""POSTN"", ""FAP""]",4,0.95,"[""Enhanced glioblastoma cell invasion through ECM modification"", ""Promotion of angiogenesis"", ""Increased tumor cell migration and therapy resistance""]"
03_NPC-neuronal-like_2_run2,3,NPC-neuronal-like 2,03_NPC-neuronal-like_2,2,1,Glutamatergic Excitotoxicity and Synapse Dynamics,"Genes encoding vesicular glutamate transporter (SLC17A6), NMDA receptor subunit (GRIN2A), synapse proteins (SYT1, SYNPR, SV2B), and auxiliary regulators (GLRA2) drive aberrant glutamatergic signaling, which is implicated in glioblastoma cell survival, migration, resistance to radiotherapy, and neuron-tumor interactions.","[""SLC17A6"", ""GRIN2A"", ""SYT1"", ""SYNPR"", ""SV2B"", ""GLRA2""]",6,0.9,"[""Potentiation of glutamate-dependent survival and migration"", ""Resistance to radiotherapy"", ""Tumor-neuron synaptic interaction in microenvironment""]"
03_NPC-neuronal-like_2_run2,3,NPC-neuronal-like 2,03_NPC-neuronal-like_2,2,2,Glioma Stem Cell Maintenance and Therapy Resistance,"GFRA1 and GDNF (via RET) signaling pathways, including associated neural transcription factors (MYT1L, CUX2, POU6F2), and ECM-remodeling proteases (ADAMTS3), underpin stem cell characteristics, self-renewal, chemoresistance, and cellular hierarchy. SEMA3C and BMP antagonists (e.g., GREM2, RUNX1T1) further maintain stemness and resistance.","[""GFRA1"", ""MYT1L"", ""CUX2"", ""POU6F2"", ""ADAMTS3"", ""SEMA3C"", ""GREM2"", ""RUNX1T1""]",8,0.89,"[""Increase in chemotherapy and radiotherapy resistance"", ""Maintenance of self-renewal and stem cell hierarchy"", ""Sustained invasive and migratory behavior""]"
04_AC-gliosis-like_1_run1,4,AC-gliosis-like 1,04_AC-gliosis-like_1,1,0,Aquaporin/ion channel invasion,"AQP1, AQP4, KCNN3, ATP1A2, and GJA1 regulate water and ion flux, supporting glioblastoma cell motility, migration, and invasion. Participation in cell shape modulation and cytoskeletal dynamics needed for perivascular and parenchymal infiltration, including interaction with integrin- and CD44-dependent machinery.","[""AQP1"", ""AQP4"", ""KCNN3"", ""ATP1A2"", ""GJA1""]",5,0.92,"[""Increased cell invasion and migration"", ""Enhanced tissue infiltration"", ""Contribution to brain parenchymal invasion""]"
04_AC-gliosis-like_1_run1,4,AC-gliosis-like 1,04_AC-gliosis-like_1,1,1,Mesenchymal transition and ECM remodeling,"CD44, HAS2, ITGB4, BCAN, SPON1, ADAMTS8, ADAMTS15, and TIMP3 mediate mesenchymal transition, ECM production, and proteolysis. These genes participate in hyaluronan synthesis, integrin signaling, and matrix-remodeling roles that drive invasiveness and resistance to therapy.","[""CD44"", ""HAS2"", ""ITGB4"", ""BCAN"", ""SPON1"", ""ADAMTS8"", ""ADAMTS15"", ""TIMP3""]",8,0.96,"[""Promoted therapy resistance via mesenchymal transformation"", ""Enhanced brain matrix remodeling, facilitating deeper infiltration"", ""Increased stem-like cell niche formation""]"
04_AC-gliosis-like_1_run1,4,AC-gliosis-like 1,04_AC-gliosis-like_1,1,2,Immune/Inflammatory microenvironment regulation,"SERPINA3, CHI3L2, C3, CFI, COLEC12, LTF, and OSMR shape tumor-associated immune cell biology. These genes recruit, polarize, or activate macrophages/microglia, contribute to immunosuppressive states, and orchestrate crosstalk with stromal and vascular cell types.","[""SERPINA3"", ""CHI3L2"", ""C3"", ""CFI"", ""COLEC12"", ""LTF"", ""OSMR""]",7,0.89,"[""Potentiated immunosuppressive niche"", ""Enhanced tumor escape from surveillance"", ""Polarization of macrophages towards pro-tumor phenotype""]"
04_AC-gliosis-like_1_run1,4,AC-gliosis-like 1,04_AC-gliosis-like_1,1,3,Stem-like state and plasticity signaling,"ID3, ID4, FABP7, FBLN5, HOPX, BMP pathway-related genes, and NOTCH effectors orchestrate stemness, differentiation block, and plasticity in glioblastoma cells. These enable tumors to repopulate and resist therapy.","[""ID3"", ""ID4"", ""FABP7"", ""FBLN5"", ""HOPX"", ""BMPR1B""]",6,0.87,"[""Renewal and expansion of tumor stem cell pool"", ""Therapy resistance via plasticity"", ""Support of intratumoral heterogeneity""]"
04_AC-gliosis-like_1_run1,4,AC-gliosis-like 1,04_AC-gliosis-like_1,1,4,Hypoxia/glycolytic metabolic adaptation,"PFKFB3, HK2, LDHA, SLC2A1, and associated glycolytic enzymes promote aggressive metabolism. Upregulation of PFKFB3 and metabolic switch facilitate adaptation to hypoxia, fuel rapid growth, and drive resistance to therapies.","[""PFKFB3""]",1,0.83,"[""Enhanced proliferation and survival in hypoxic microenvironment"", ""Metabolic resistance to therapy"", ""Increased invasion by fuel provision""]"
04_AC-gliosis-like_1_run1,4,AC-gliosis-like 1,04_AC-gliosis-like_1,1,5,Angiogenesis and vascular niche formation,"EDNRA, EDNRB, F3, PDGFRB, IGFBP7, BMPR1B are implicated in blood vessel formation, endothelial-pericyte communication, and vascular niche maintenance. Promotion of neovascularization supports glioblastoma growth and therapeutic resistance.","[""EDNRA"", ""EDNRB"", ""PDGFRB"", ""F3"", ""IGFBP7"", ""BMPR1B""]",6,0.91,"[""Accelerated neovascularization and microenvironment remodeling"", ""Support of GBM expansion and therapy resistance"", ""Enhanced perivascular stem cell niche formation""]"
04_AC-gliosis-like_1_run2,4,AC-gliosis-like 1,04_AC-gliosis-like_1,2,0,Aquaporin/Ion Channel-Driven Migration,"Upregulation of aquaporins (AQP1, AQP4) and ion channels (KCNN3) in glioblastoma enhances cell motility, invasion, and peritumoral edema. These genes mediate water and ion fluxes supporting cellular migration through brain tissue and are associated with tumor progression and poor prognosis.","[""AQP1"", ""AQP4"", ""KCNN3""]",3,0.9,"[""increased cell motility and invasion"", ""edema formation""]"
04_AC-gliosis-like_1_run2,4,AC-gliosis-like 1,04_AC-gliosis-like_1,2,1,Reactive Astrocyte-Like State and Stemness,"Glioblastoma cells commonly activate programs resembling reactive astrocytes and stem-cell markers. Canonical astrocyte genes (GFAP, ALDH1L1, GJA1) and stemness regulators (CD44, ID3, ID4) drive invasiveness and therapeutic resistance, partly via modulation of the tumor microenvironment and maintenance of stem-like populations.","[""GFAP"", ""ALDH1L1"", ""GJA1"", ""CD44"", ""ID3"", ""ID4""]",6,0.95,"[""enhanced invasion"", ""resistance to therapy"", ""maintenance of stem-like tumor cell populations""]"
04_AC-gliosis-like_1_run2,4,AC-gliosis-like 1,04_AC-gliosis-like_1,2,2,ECM Remodeling and Cell-Cell Adhesion,"Genes regulating extracellular matrix composition (BCAN, HAS2, FBLN5, COL28A1, PAPLN, TIMP3, ADAMTS family) and adhesion (ITGB4, SPON1) jointly enable GBM cells to invade neural parenchyma, remodel their environment, and resist therapy. Hyaluronan synthase (HAS2), brevican, integrins, and tissue inhibitors of metalloproteinases coordinate motility, matrix breakdown, and structural adaptation.","[""HAS2"", ""BCAN"", ""FBLN5"", ""COL28A1"", ""PAPLN"", ""TIMP3"", ""ITGB4"", ""SPON1"", ""ADAMTS8"", ""ADAMTS15""]",10,0.92,"[""increased local invasion through matrix breakdown"", ""remodeling of peritumoral ECM"", ""adaptability to microenvironmental changes""]"
04_AC-gliosis-like_1_run2,4,AC-gliosis-like 1,04_AC-gliosis-like_1,2,3,Angiogenesis and Vascular Remodeling,"Endothelial growth, angiogenic signaling, and hypoxia adaptation are mediated by PDGFRB, EGF, F3 (tissue factor), EDNRA, EDNRB. These factors collectively drive neovascularization, enhance GBM metabolic support, and promote invasion. Altered expression of these genes correlates with resistance to anti-angiogenic therapy.","[""PDGFRB"", ""EGF"", ""F3"", ""EDNRA"", ""EDNRB""]",5,0.88,"[""enhanced neovascularization"", ""resistance to antiangiogenic treatment""]"
04_AC-gliosis-like_1_run2,4,AC-gliosis-like 1,04_AC-gliosis-like_1,2,4,"Immunomodulation, Hypoxia, and Inflammation","Dysregulated inflammatory signaling (SERPINA3, C3, CHI3L2) modifies immune infiltration, induces immune suppression, and fosters tumor progression. Complement activation promotes hypoxia adaptation and angiogenesis through C3/C3aR; SERPINA3 facilitates invasion and suppresses apoptosis in stem-like GBM cells. CHI3L2 expression is associated with immune cell exhaustion.","[""SERPINA3"", ""C3"", ""CHI3L2""]",3,0.85,"[""increased immune evasion"", ""microenvironment adaptation"", ""promotion of angiogenesis""]"
04_AC-gliosis-like_1_run2,4,AC-gliosis-like 1,04_AC-gliosis-like_1,2,5,Metabolic Adaptation and Glycolysis,"Upregulation of key glycolysis enzymes such as PFKFB3 supports rapid cell proliferation and survival under hypoxic conditions. Metabolic rewiring includes lactate efflux, glutamine utilization, and altered mitochondrial activity, enabling GBM cells to survive, proliferate, and resist cytotoxic therapies.","[""PFKFB3""]",1,0.82,"[""enhanced proliferation"", ""survival under hypoxia""]"
04_AC-gliosis-like_1_run2,4,AC-gliosis-like 1,04_AC-gliosis-like_1,2,6,Mesenchymal State Induction via Cytokine Receptors,"OSMR, via JAK/STAT3 signaling, induces M2 macrophage polarization and supports mesenchymal transition, promoting tumor growth, immune evasion, and therapy resistance. GBM cells with high OSMR expression exhibit enhanced stem-like and mesenchymal features.","[""OSMR""]",1,0.8,"[""enhanced mesenchymal properties"", ""therapy resistance"", ""promotion of immune evasion""]"
05_AC-neuronal-like_run1,5,AC-neuronal-like,05_AC-neuronal-like,1,0,Glioblastoma Invasion & Migration,"Key genes drive cytoskeletal remodeling, cell adhesion changes, and matrix degradation for GBM cell invasion. This program integrates ECM proteases (ADAMTS18, ADAM28, TGM2), cytoskeletal regulators (SEPTIN14, TRPV4), cell adhesion molecules (PCDH11X, CNTNAP2, DOCK2), matrix proteins (POSTN, COL12A1, COL19A1), and migration cues (RELN, SLIT2, WNT16). Notably, POSTN promotes macrophage recruitment and invasion, TGM2 is essential for survival and stemness during invasion, and TRPV4 facilitates F-actin dependent protrusions critical for migration.","[""POSTN"", ""ADAMTS18"", ""ADAM28"", ""COL12A1"", ""COL19A1"", ""SEPTIN14"", ""TRPV4"", ""PCDH11X"", ""CNTNAP2"", ""RELN"", ""SLIT2"", ""WNT16""]",12,0.97,"[""enhanced ECM remodeling and breakdown"", ""increased cytoskeletal plasticity"", ""promoted cell migratory behavior"", ""facilitated immune cell recruitment via POSTN""]"
05_AC-neuronal-like_run1,5,AC-neuronal-like,05_AC-neuronal-like,1,1,Glioblastoma Immune Suppression,"A group of macrophage, microglia, and immunological regulatory genes (CD163, VSIG4, MSR1, INPP5D, IL7, CD96) cooperate in skewing the glioblastoma environment toward immune evasion. CD163, MSR1 and VSIG4 drive M2-like immunosuppressive macrophage phenotypes. INPP5D regulates myeloid cell signaling. CD96 acts as an NK cell/T cell checkpoint, and IL7 stimulation is epigenetically silenced, hampering adaptive immunity.","[""CD163"", ""VSIG4"", ""MSR1"", ""INPP5D"", ""CD96"", ""IL7""]",6,0.93,"[""immunosuppressive microenvironment establishment"", ""reduced lymphocytic infiltration and activity"", ""enhanced tumor resistance to immunotherapy""]"
05_AC-neuronal-like_run1,5,AC-neuronal-like,05_AC-neuronal-like,1,2,Glioblastoma Stem Cell Maintenance & Therapy Resistance,"Genes such as WNT16, ALDH1A2, HMGA2, BIRC3, and TGM2 join with pathways supporting stemness, therapy resistance, and tumor recurrence. WNT signaling drives stem cell self-renewal and radiotherapy resistance. ALDH1A2 and HMGA2 support stemness and expansion. BIRC3 enables apoptosis resistance and is directly tied to therapy adaptation. TGM2 links stemness, survival, and resistance in the mesenchymal GBM subtype.","[""WNT16"", ""ALDH1A2"", ""HMGA2"", ""BIRC3"", ""TGM2""]",5,0.95,"[""increased tumor recurrence and therapy resistance"", ""promotion of glioma stem-like cell self-renewal and proliferation"", ""mesenchymal transformation supporting invasion""]"
05_AC-neuronal-like_run1,5,AC-neuronal-like,05_AC-neuronal-like,1,3,Glioblastoma Angiogenesis & Hypoxic Adaptation,"Core angiogenic and hypoxia-responsive genes (VEGFD, TEK, FAP, PLIN2) collaborate to drive neovascularization and metabolic reprogramming. VEGFD and TEK (TIE2) are critical endothelial regulators. FAP+ mesenchymal cells cooperate with endothelial cells and support pro-angiogenic microenvironment. PLIN2 and related lipid droplet proteins adapt GBM cells to hypoxic metabolic stress.","[""VEGFD"", ""TEK"", ""FAP"", ""PLIN2""]",4,0.9,"[""enhanced neovascularization for tumor support"", ""adaptation to hypoxic microenvironments"", ""potential increased therapy resistance""]"
05_AC-neuronal-like_run2,5,AC-neuronal-like,05_AC-neuronal-like,2,0,Mesenchymal Invasion & EMT,"Coordinated upregulation of ECM-remodeling proteins (POSTN, TNC, COL19A1, ADAMTSs, SPOCK3), cell adhesion molecules (e.g., PCDH7, PCDH11X), and EMT regulators (HMGA2, RELN) highlight a mesenchymal gene program driving glioblastoma cell invasion. Matrix-crosslinking enzymes (TGM2) and pathways supporting cell migration and transition are collectively strengthened.","[""POSTN"", ""TNC"", ""COL19A1"", ""COL12A1"", ""ADAMTS18"", ""SPOCK3"", ""TGM2"", ""HMGA2"", ""RELN""]",9,0.95,"[""Enhanced invasion and migration"", ""Mesenchymal phenotype acquisition"", ""Resistance to therapy via EMT and ECM remodeling""]"
05_AC-neuronal-like_run2,5,AC-neuronal-like,05_AC-neuronal-like,2,1,Immune Evasion & TAM Polarization,"Genes such as MSR1, CD163, ALDH1A2, SULF1, TLR2, OLR1, and others are involved in immunosuppressive microenvironment creation, recruitment/activation of M2-like tumor-associated macrophages (TAMs), and resistance to immune-driven attack.","[""MSR1"", ""CD163"", ""ALDH1A2"", ""SULF1"", ""TLR2"", ""OLR1"", ""INPP5D""]",7,0.9,"[""Immunosuppressive microenvironment"", ""Promotion of M2-like TAMs"", ""Therapy resistance via immune evasion""]"
05_AC-neuronal-like_run2,5,AC-neuronal-like,05_AC-neuronal-like,2,2,Calcium & Glutamate Signaling,"Genes like RYR2, GRIN2B, TRPM8, TRPV4 and related ion channels coordinate calcium and glutamate-dependent signal transduction, which drive tumor cell excitability, migration, self-renewal, and therapy resistance in glioblastoma.","[""RYR2"", ""TRPM8"", ""TRPV4"", ""GRIN2B""]",4,0.8,"[""Enhanced excitability and migration"", ""Therapy resistance from altered Ca2+/glutamate signaling"", ""Promotion of stemness via NMDAR""]"
05_AC-neuronal-like_run2,5,AC-neuronal-like,05_AC-neuronal-like,2,3,Stemness & Plasticity Regulation,"Upregulation of HMGA2, ALDH1A2, NLGN4X collectively indicate an epigenetic and cell surface adhesive program promoting glioblastoma stem cell self-renewal and plasticity.","[""HMGA2"", ""ALDH1A2"", ""NLGN4X""]",3,0.75,"[""Increased self-renewal/plasticity"", ""Promotion of resistant, multipotent tumor cells""]"
06_OPC-NPC-like_run1,6,OPC-NPC-like,06_OPC-NPC-like,1,0,Sonic Hedgehog and GLI Signaling,"Central to glioblastoma stemness, proliferation, and invasion. GLI2 and SHH pathway components are highly active and drive tumor progression, acting through regulatory networks that also support resistance and plasticity.","[""GLI2"", ""EGFR"", ""DLX5"", ""DLX6""]",4,0.92,"[""enhanced proliferation and migration"", ""maintenance of cancer stem cell properties"", ""resistance to differentiation and therapy""]"
06_OPC-NPC-like_run1,6,OPC-NPC-like,06_OPC-NPC-like,1,1,Notch Signaling,"Key regulator of glioblastoma stem cell maintenance, proliferation, apoptosis resistance and therapy resistance. DLL1 and NOTCH axis are hyperactive in GBM.","[""DLL1""]",1,0.88,"[""cancer stem cell maintenance"", ""apoptosis resistance"", ""poor response to standard therapies""]"
06_OPC-NPC-like_run1,6,OPC-NPC-like,06_OPC-NPC-like,1,2,EGFR/ERBB Family Signaling,"EGFR and ERBB3 jointly drive growth, survival, invasion, and resistance in GBM. EGFR amplification, mutation, and ERBB compensation are classic mechanisms of targeted therapy resistance.","[""EGFR"", ""ERBB3""]",2,0.94,"[""sustained proliferation"", ""evasion of apoptosis"", ""enhanced invasion and therapy resistance""]"
06_OPC-NPC-like_run1,6,OPC-NPC-like,06_OPC-NPC-like,1,3,Stemness and Dedifferentiation Program,"SOX2, LGR5 and GLI2 promote stem-like properties, therapy resistance, and tumor recurrence in GBM. This state serves as a reservoir for relapse.","[""SOX2-OT"", ""LGR5"", ""GLI2""]",3,0.95,"[""enforced stemness and therapy resistance"", ""tumor recurrence from stem cell pool"", ""de-differentiation of progenitors""]"
06_OPC-NPC-like_run1,6,OPC-NPC-like,06_OPC-NPC-like,1,4,Mesenchymal Transition & Invasion,"PRRX1 and RELN promote invasion via EMT-like programs, with supporting roles from extracellular matrix and cell adhesion molecules. This program is central to GBM malignancy and resistance.","[""PRRX1"", ""RELN"", ""FREM2"", ""STC1""]",4,0.87,"[""increased invasion and migration"", ""therapy resistance"", ""poor patient survival""]"
06_OPC-NPC-like_run1,6,OPC-NPC-like,06_OPC-NPC-like,1,5,Immunosuppression,"LGALS1 and ISG15 mediate immunosuppressive microenvironment in glioblastoma, supporting tumor evasion and resistance to immunotherapy.","[""LGALS1"", ""ISG15""]",2,0.91,"[""strong local and systemic immunosuppression"", ""evasion of host immune response"", ""poor response to immunotherapy""]"
06_OPC-NPC-like_run2,6,OPC-NPC-like,06_OPC-NPC-like,2,0,RTK/RAS/PI3K Pathway Activation,"Core glioblastoma oncogenic signaling driven by EGFR and ERBB3 amplification and mutation, with supporting genes including MDK, GRK5, and downstream regulators of proliferation and survival.","[""EGFR"", ""ERBB3"", ""MDK"", ""GRK5""]",4,0.95,"[""enhanced proliferation"", ""robust survival signaling"", ""hyperactivated metabolic networks"", ""therapy resistance""]"
06_OPC-NPC-like_run2,6,OPC-NPC-like,06_OPC-NPC-like,2,1,Proneural-Mesenchymal Transition & Stem Cell Plasticity,"GBM manifests plasticity between proneural and mesenchymal cell states, driven by core factors (SOX2, DLL1, PRRX1, RELN, MEIS2) and lncRNAs (MALAT1) with a supporting role for EMT drivers and neurodevelopmental transcription factors.","[""SOX2-OT"", ""SOX2"", ""DLL1"", ""LGR5"", ""PRRX1"", ""RELN"", ""MEIS2"", ""MALAT1""]",8,0.93,"[""increased tumor plasticity"", ""fast adaptation to microenvironmental shifts"", ""therapy resistance (especially to radiotherapy/chemotherapy)"", ""capacity to transition between neural and mesenchymal lineages""]"
06_OPC-NPC-like_run2,6,OPC-NPC-like,06_OPC-NPC-like,2,2,"Aberrant Translation, Ribosome Biogenesis, and Metabolic Adaptation","Multiple ribosomal proteins (RPLs, RPSs) and translation regulators are upregulated in glioblastoma, supporting high protein synthesis, metabolic rewiring, and therapy resistance.","[""RPL18A"", ""RPL13A"", ""RPL8"", ""RPS18"", ""RPL10"", ""RPL7"", ""RPL32"", ""RPL41"", ""RPL34"", ""RPL36"", ""RPL28""]",11,0.89,"[""increased protein synthesis capacity"", ""rapid proliferation under stress"", ""therapy resistance"", ""metabolic flexibility""]"
06_OPC-NPC-like_run2,6,OPC-NPC-like,06_OPC-NPC-like,2,3,Apoptosis and Therapy Resistance Programs,"Activation of intrinsic mitochondrial apoptosis pathways via CASP9, combined with resistance mechanisms including polyamine metabolism (SAT1), cell cycle control by BTG2, and ISG15-driven immune evasion.","[""CASP9"", ""SAT1"", ""ISG15"", ""BTG2""]",4,0.86,"[""resistance to apoptosis"", ""modulation of immune cell infiltration"", ""enhanced therapy resistance"", ""control of tumor microenvironment signaling""]"
06_OPC-NPC-like_run2,6,OPC-NPC-like,06_OPC-NPC-like,2,4,"Neural and Axon Guidance, Migration","Multiple neural development/axon guidance genes (SLIT3, UNC5B, NTNG2, FLRT2, EPHA7, RELN, DLL1, EFNA5) regulate migration, invasion, and differentiation in the neural microenvironment, promoting cell dispersal and network interactions within the brain.","[""SLIT3"", ""UNC5B"", ""NTNG2"", ""FLRT2"", ""EPHA7"", ""RELN"", ""DLL1"", ""EFNA5"", ""GRIN3A""]",9,0.84,"[""promotes neural cell migration and invasion"", ""supports neural differentiation within tumor mass"", ""facilitates adaptability in neural tissue microenvironment""]"
07_Proliferative_run1,7,Proliferative,07_Proliferative,1,0,Cell Cycle Checkpoint Control,"Genes governing G1/S and G2/M phase transitions, spindle assembly checkpoint, and mitotic progression through CDK activation and cyclin-mediated regulation. Core cell cycle machinery dysregulated in GBM.","[""CDK1"", ""CCNB1"", ""CCNB2"", ""CDC25C"", ""TTK"", ""CDC20"", ""CDCA2"", ""CDCA8"", ""RRM2""]",9,0.95,"[""Uncontrolled G2/M transition and mitotic progression"", ""Shortened G2/M checkpoint, enabling rapid proliferation despite DNA damage"", ""Overriding normal cell cycle checkpoints driving malignant proliferation"", ""Enhanced genomic instability through checkpoint evasion""]"
07_Proliferative_run1,7,Proliferative,07_Proliferative,1,1,Spindle Assembly Checkpoint,"Coordinate regulation of kinetochore-microtubule attachment monitoring, spindle checkpoint complex assembly, and anaphase entry prevention during mitosis. Essential for accurate chromosome segregation.","[""TTK"", ""BUB1"", ""BUB1B"", ""KNL1"", ""NDC80"", ""SKA3"", ""NUF2"", ""CENPI"", ""CDC20"", ""PTTG1"", ""ESPL1""]",11,0.92,"[""Partial checkpoint override enabling mitosis with chromosomal errors"", ""Aneuploidy and chromosomal instability driving tumor heterogeneity"", ""Enhanced checkpoint activation in some cells leading to prolonged mitosis"", ""Unequal checkpoint fidelity across GBM cell population""]"
07_Proliferative_run1,7,Proliferative,07_Proliferative,1,2,Aurora Kinase Signaling,"Regulation of centrosome duplication, spindle pole organization, kinetochore function, and mitotic progression through Aurora A and B kinase activities. Critical for genomic stability.","[""AURKA"", ""AURKB"", ""TPX2"", ""NUSAP1"", ""ASPM"", ""STIL"", ""RACGAP1"", ""ECT2""]",8,0.91,"[""Enhanced centrosome duplication driving mitotic abnormalities"", ""Improved spindle assembly efficiency enabling rapid cell division"", ""Increased genomic instability through supernumerary centrosomes"", ""Enhanced survival through AURKA-mediated immune checkpoint modulation (B7-H3, PD-L1)""]"
07_Proliferative_run1,7,Proliferative,07_Proliferative,1,3,Transcriptional Cell Cycle Regulation,"Transcription factor networks controlling G1/S and G2/M phase gene expression, particularly FOXM1, E2F, and B-MYB pathways. Master regulators of cell cycle gene expression in GBM.","[""FOXM1"", ""E2F7"", ""MYBL2"", ""MELK"", ""CCNB1"", ""CCNB2"", ""CDK1"", ""PTTG1""]",8,0.93,"[""Constitutive G1/S and G2/M phase transcription programs"", ""Enhanced mitotic kinase expression independent of cell cycle phase"", ""Glioma stem cell maintenance through FOXM1-MELK axis"", ""Radioresistance through FOXM1-mediated pathways""]"
07_Proliferative_run1,7,Proliferative,07_Proliferative,1,4,Kinesin Motor Protein Function,"Diverse kinesin family members mediating spindle formation, chromosome alignment, kinetochore function, and cytokinesis through microtubule-based transport.","[""KIF11"", ""KIF15"", ""KIF2C"", ""KIF18A"", ""KIF20A"", ""KIF4A"", ""KIFC1"", ""KIF14"", ""KIF24"", ""TPX2"", ""NUSAP1"", ""CENPE""]",12,0.9,"[""Enhanced spindle assembly enabling rapid mitotic progression"", ""Improved chromosome alignment through KIF-mediated transport"", ""KIF18A-driven proliferation and recurrence in GBM"", ""Potential mitotic errors from kinesin dysregulation""]"
07_Proliferative_run1,7,Proliferative,07_Proliferative,1,5,Centromere and Kinetochore Assembly,"CENP family proteins, NDC80 complex, and associated factors mediating centromere protein A deposition, kinetochore assembly, and maintenance of centromeric heterochromatin.","[""HJURP"", ""CENPI"", ""CENPF"", ""NDC80"", ""NUF2"", ""SPC25"", ""SKA3"", ""KNL1"", ""CENPE""]",9,0.88,"[""Enhanced centromere assembly supporting rapid cell division"", ""Improved kinetochore-microtubule attachment fidelity"", ""Potential centromere amplification driving genomic instability"", ""Enhanced mitotic fidelity through HJURP overexpression""]"
07_Proliferative_run1,7,Proliferative,07_Proliferative,1,6,Mitotic Kinase Cascades,"Hierarchical kinase signaling networks including CDK1, ERK, GSK3, and checkpoint kinases that synchronize mitotic events and regulate spindle dynamics.","[""MELK"", ""CDK1"", ""AURKA"", ""AURKB"", ""PLK1"", ""TTK"", ""BUB1"", ""FOXM1""]",8,0.89,"[""Rapid mitotic checkpoint progression through MELK-FOXM1 axis"", ""Enhanced tumor cell survival under replication stress"", ""G1/S phase checkpoint override enabling rapid S-phase entry"", ""Treatment resistance through kinase network redundancy""]"
07_Proliferative_run1,7,Proliferative,07_Proliferative,1,7,DNA Replication and S-Phase Progression,"DNA polymerase, ligase, and replication fork processing proteins supporting S-phase progression, fork stability, and replication stress responses.","[""RRM2"", ""POLQ"", ""PIF1"", ""NEIL3"", ""BRIP1"", ""EXO1"", ""ASPM"", ""CDT1""]",8,0.84,"[""Enhanced dNTP availability supporting rapid DNA synthesis"", ""Stabilized replication forks under genotoxic stress"", ""Translesion synthesis capacity enabling replication past DNA damage"", ""Potential treatment resistance through replication stress adaptation""]"
07_Proliferative_run1,7,Proliferative,07_Proliferative,1,8,Sister Chromatid Cohesion and Separation,"Cohesin complex regulation, cohesion establishment/dissolution, and separase-mediated sister chromatid separation during mitotic progression.","[""ESCO2"", ""ESPL1"", ""SGO1"", ""SGO2"", ""SHCBP1"", ""PTTG1"", ""CDC20""]",7,0.83,"[""Robust sister chromatid cohesion enabling accurate segregation"", ""Controlled cohesion dissolution at anaphase entry"", ""Centromeric cohesion protection through shugoshin function"", ""Potential aneuploidy from cohesion defects""]"
07_Proliferative_run1,7,Proliferative,07_Proliferative,1,9,Apoptosis Inhibition and Cell Survival,"IAP family proteins, particularly survivin (BIRC5), mediating inhibition of caspases and blocking programmed cell death in GBM.","[""BIRC5"", ""PIF1"", ""MELK"", ""FOXM1"", ""CCNB1""]",5,0.87,"[""Blocked apoptosis enabling survival despite DNA damage"", ""Enhanced aerobic glycolysis through mitochondrial survivin"", ""Mitotic survival enabling cells with chromosomal errors to complete division"", ""Treatment resistance through multiple anti-apoptotic mechanisms""]"
07_Proliferative_run1,7,Proliferative,07_Proliferative,1,10,Condensin-Mediated Chromosome Condensation,"Non-SMC condensin complex proteins mediating chromosome condensation, compaction, and segregation during mitosis.","[""NCAPG"", ""NCAPH""]",2,0.82,"[""Efficient chromosome condensation enabling rapid mitosis"", ""Improved chromosome segregation accuracy"", ""Enhanced PARP1-E2F1 signaling driving proliferation"", ""Poor prognosis correlation with high NCAPG expression""]"
07_Proliferative_run2,7,Proliferative,07_Proliferative,2,0,Mitotic Cell Division Promotion,"A large cluster of input genes collectively regulate mitosis in glioblastoma cells including kinetochore-microtubule attachments, spindle assembly, chromosome segregation, and cytokinesis. This program encompasses both normal cell division and the hyperproliferative phenotype in malignancy.","[""TTK"", ""BUB1"", ""BUB1B"", ""KNL1"", ""CDC20"", ""CENPE"", ""NDC80"", ""SKA3"", ""NUF2"", ""CENPF"", ""SPC25"", ""ESPL1"", ""PTTG1"", ""SGO1"", ""SGO2"", ""ECT2"", ""RACGAP1"", ""KIF23"", ""PRC1"", ""KIF14"", ""KIF20A"", ""KIF4A"", ""ARHGAP11A"", ""ARHGAP11B"", ""SHCBP1"", ""KIF11"", ""TPX2"", ""CEP55"", ""ASPM"", ""STIL""]",30,1.0,"[""Increased mitotic rate and proliferation"", ""Aneuploidy and chromosome instability"", ""Enhanced tumor aggressiveness""]"
07_Proliferative_run2,7,Proliferative,07_Proliferative,2,1,Cell Cycle Progression and DNA Replication,"Cell cycle checkpoint regulators, cyclins, and DNA replication/repair enzymes are highly expressed, ensuring cell cycle entry and DNA synthesis in malignant glioblastoma. Aberrations drive uncontrolled proliferation and therapy resistance.","[""CDCA2"", ""CDC25C"", ""CDK1"", ""CCNB1"", ""CCNB2"", ""CCNF"", ""CDKN3"", ""PBK"", ""TOP2A"", ""RRM2"", ""BRIP1"", ""POLQ"", ""EXO1"", ""NEIL3""]",14,0.98,"[""Uncontrolled cell cycle progression"", ""Resistance to DNA damaging therapies"", ""Increased genomic instability""]"
07_Proliferative_run2,7,Proliferative,07_Proliferative,2,2,Stemness and Tumorigenicity Drivers,"Genes such as HMMR, ASPM, MKI67, FOXM1, and MELK maintain the stemness, self-renewal, and tumorigenic capacity of glioblastoma cells, contributing to resistance and recurrence.","[""HMMR"", ""ASPM"", ""MKI67"", ""FOXM1"", ""MELK""]",5,0.96,"[""Increased tumor initiation, recurrence, and resistance"", ""Enhanced proliferation and invasiveness"", ""Maintenance of glioma stem cell populations""]"
08_Gliosis-hypoxia_run1,8,Gliosis-hypoxia,08_Gliosis-hypoxia,1,0,Hypoxia Response & Survival,"Upregulation of hypoxia-adaptive genes promoting glycolytic switch, proangiogenic signaling, autophagy, and therapy resistance; extensive literature implicates ANGPTL4, HILPDA, BNIP3L, NDRG1, TRIB3, LUCAT1 as a hypoxia-adaptive cluster that links metabolic stress to increased invasion, therapy evasion, and immune suppression.","[""ANGPTL4"", ""HILPDA"", ""BNIP3L"", ""NDRG1"", ""TRIB3"", ""LUCAT1""]",6,0.98,"[""increased therapy resistance"", ""enhanced tumor invasiveness"", ""immune escape""]"
08_Gliosis-hypoxia_run1,8,Gliosis-hypoxia,08_Gliosis-hypoxia,1,1,Mesenchymal Transition & Invasion,"Coordinated activation of EMT and mesenchymal-associated genes (RUNX2, ITGB3, CAV1, COL5A1, COL13A1, COL24A1, ABI3BP) drives cytoskeletal remodeling, cell migration, and infiltrative tumor behavior in GBM.","[""RUNX2"", ""ITGB3"", ""CAV1"", ""COL5A1"", ""COL13A1"", ""COL24A1"", ""ABI3BP"", ""PHLDB2""]",8,0.95,"[""increased migration and invasion"", ""tumor infiltration"", ""ECM remodeling""]"
08_Gliosis-hypoxia_run1,8,Gliosis-hypoxia,08_Gliosis-hypoxia,1,2,Angiogenesis & Vascular Niche,"PTGS2, ANGPTL4, HILPDA, and ITGB3 cluster with hypoxia and angiogenic genes to drive neovascularization, abnormal microvasculature, and support tumor progression in glioblastoma.","[""ANGPTL4"", ""PTGS2"", ""ITGB3"", ""HILPDA""]",4,0.94,"[""enhanced neovascularization"", ""support of stem-like cell populations"", ""therapy resistance via vascular niche""]"
08_Gliosis-hypoxia_run1,8,Gliosis-hypoxia,08_Gliosis-hypoxia,1,3,EGFR-MET Oncogenic Signaling & Feedback,"MET acts with ERRFI1 (negative EGFR feedback) and CAV1 to regulate growth factor signaling, promoting proliferation and invasion; feedback disruption is common in glioblastoma and leads to resistance against targeted therapies.","[""MET"", ""ERRFI1"", ""CAV1""]",3,0.93,"[""amplified cell proliferation"", ""signal feedback disruption"", ""targeted therapy resistance""]"
08_Gliosis-hypoxia_run2,8,Gliosis-hypoxia,08_Gliosis-hypoxia,2,0,Mesenchymal transition & Invasion,"Collective dysregulation of several input genes (RUNX2, ITGB3, CAV1, COL5A1, NOX4, OSMR, TRIB3, EPHA3, LTBP2, CAV1) is tightly linked to the acquisition of mesenchymal states, increased motility, invasiveness, and therapy resistance in glioblastoma through signaling pathways like TGF-beta/NOX4, integrin-ECM adhesion, focal adhesion remodeling, and reorganization of ECM components.","[""RUNX2"", ""NOX4"", ""COL5A1"", ""OSMR"", ""ITGB3"", ""CAV1"", ""TRIB3"", ""LTBP2"", ""EPHA3""]",9,0.97,"[""Increased cell migration and invasion"", ""Therapy resistance"", ""Stem-like program enrichment"", ""Aberrant ECM deposition and reorganization""]"
08_Gliosis-hypoxia_run2,8,Gliosis-hypoxia,08_Gliosis-hypoxia,2,1,Hypoxia and metabolic reprogramming,"Major input genes (HILPDA, BNIP3L, NDRG1, NOX4, HMOX1, ANGPTL4, COL24A1, COL5A1, EPSTI1, LUCAT1) are strongly induced by hypoxia in malignant glioblastoma; these drive adaptation to low oxygen, oxidative stress resistance, altered glycolysis/fatty acid metabolism, and angiogenesis.","[""HILPDA"", ""NOX4"", ""COL5A1"", ""NDRG1"", ""BNIP3L"", ""HMOX1"", ""ANGPTL4"", ""EPSTI1"", ""EHHADH""]",9,0.93,"[""Enhanced survival in low oxygen"", ""Oxidative stress resistance"", ""Metabolic flexibility"", ""Angiogenesis induction""]"
08_Gliosis-hypoxia_run2,8,Gliosis-hypoxia,08_Gliosis-hypoxia,2,2,Growth factor & receptor tyrosine signaling,"Joint upregulation of MET, EPHA3, OSMR, ERRFI1, PRKCH, FAT4, CDON, SHISA6, EPHA1-AS1, and integrin ITGB3 conveys amplified growth signaling via receptor tyrosine kinases, EGFR pathway feedback loops, JAK-STAT, and Hippo pathway alterations in glioblastoma.","[""MET"", ""EPHA3"", ""ERRFI1"", ""OSMR"", ""PRKCH"", ""FAT4"", ""CDON"", ""ITGB3""]",8,0.91,"[""Amplified proliferation signaling"", ""Resistance to EGFR inhibition"", ""Mesenchymal program induction""]"
08_Gliosis-hypoxia_run2,8,Gliosis-hypoxia,08_Gliosis-hypoxia,2,3,Purine and fatty acid metabolism,"Increased expression of nucleotide (AMPD3) and fatty acid metabolism genes (EHHADH, COL5A1, COL24A1, ANGPTL4, NOX4, SLC39A14) supports glioblastoma cell bioenergetics and survival in nutrient-poor microenvironment.","[""AMPD3"", ""EHHADH"", ""NOX4"", ""COL5A1"", ""COL24A1"", ""ANGPTL4"", ""SLC39A14""]",7,0.88,"[""Enhanced nucleotide supply for proliferation"", ""FAO-driven survival in nutrient stress"", ""Chemoresistance""]"
08_Gliosis-hypoxia_run2,8,Gliosis-hypoxia,08_Gliosis-hypoxia,2,4,Cell stress and apoptosis regulation,"BNIP3L, UNC5C, HMOX1, TRIB3, NDRG1, CAV1 coordinate stress and apoptotic/survival pathways, impacting glioblastoma therapy resistance and stemness. BNIP3L, NDRG1 mediate hypoxia-induced autophagy; UNC5C as dependence receptor induces apoptosis in absence of ligand; TRIB3 regulates autophagy and ER stress.","[""BNIP3L"", ""TRIB3"", ""NDRG1"", ""HMOX1"", ""UNC5C"", ""CAV1""]",6,0.82,"[""Therapy resistance via stress adaptation"", ""Increased survival under apoptosis-inducing cues"", ""Stem-like phenotype maintenance""]"
09_Proliferative_2_run1,9,Proliferative 2,09_Proliferative_2,1,0,DNA Replication Licensing & Fork Progression,"Includes MCM family (MCM2,4,5,6,10), CDC45, GINS1, WDHD1, ORC6, RFC2/3, POLE2, POLA1/2, PCNA, CLSPN, CHAF1A/B, ASF1B. These genes together constitute key components for origin licensing, replisome assembly, and elongation machinery. Aberrant activity and overexpression drive rapid DNA replication and replicative stress characteristic of glioblastoma.","[""MCM2"", ""MCM4"", ""MCM5"", ""MCM6"", ""MCM10"", ""CDC45"", ""GINS1"", ""WDHD1"", ""ORC6"", ""RFC2"", ""RFC3"", ""PCNA"", ""ASF1B"", ""CHAF1A"", ""CHAF1B"", ""CLSPN"", ""POLE2"", ""POLA1"", ""POLA2""]",19,0.95,"[""Permissive replication origin licensing and increased fork firing enable rapid proliferation"", ""High replicative stress promoting genome instability"", ""Targets for synthetic lethality in combination therapies""]"
09_Proliferative_2_run1,9,Proliferative 2,09_Proliferative_2,1,1,Cell Cycle Regulation & Checkpoint Control,"Genes such as E2F1, E2F7, CCNE2, FOXM1, CHEK1, CLSPN, CDC45 regulate G1/S transition, S phase progression, and checkpoint enforcement. Glioblastoma displays hyperactivation and dysregulation, permitting uncontrolled division and resistance to genotoxic therapy.","[""E2F1"", ""E2F7"", ""CCNE2"", ""FOXM1"", ""CHEK1"", ""CLSPN"", ""CDC45"", ""CDC45"", ""CDC45"", ""WDR62"", ""SKA3"", ""KIF15"", ""KIF24""]",13,0.87,"[""Accelerated S phase entry and division"", ""Checkpoint evasion promotes survival and chromosomal instability"", ""Potential for synthetic lethality via checkpoint inhibition""]"
09_Proliferative_2_run1,9,Proliferative 2,09_Proliferative_2,1,2,"DNA Damage Response & Repair (HR, FA, TLS)","Fanconi anemia pathway (FANCA, FANCB, FANCI, FANCD2), Homologous recombination (BRCA1/2, RAD51, RAD18, XRCC2, RAD54L, BRIP1), and translesion synthesis (RAD18, POLQ, DNA2, LIG1) genes ensure DNA repair under stress. High expression supports adaptation to genotoxic stress in glioblastoma.","[""FANCA"", ""FANCB"", ""FANCI"", ""FANCD2"", ""BRCA1"", ""BRCA2"", ""RAD54L"", ""RAD51"", ""RAD51AP1"", ""XRCC2"", ""BRIP1"", ""RAD18"", ""POLQ"", ""DNA2"", ""LIG1""]",15,0.88,"[""Enhanced DNA repair capacity supports tumor survival under replicative/genotoxic stress"", ""Facilitates resistance to radiation and chemotherapy"", ""Potential to target as vulnerabilities in therapy""]"
09_Proliferative_2_run1,9,Proliferative 2,09_Proliferative_2,1,3,Chromatin Remodeling & Epigenetic Regulation,"ASF1B, CHAF1A/B, UHRF1, HMGB2, HMGN2, HELLS, ESCO2, ATAD2, DNMT1 and associated factors regulate chromatin structure, histone modification, and DNA methylation. Dysregulation modulates DNA accessibility for replication, transcription, and repair, permitting oncogenic programs.","[""ASF1B"", ""CHAF1A"", ""CHAF1B"", ""UHRF1"", ""HMGB2"", ""HMGN2"", ""HELLS"", ""ESCO2"", ""ATAD2""]",9,0.78,"[""Permissive chromatin states increase accessibility for replication and transcription"", ""Epigenetic silencing of tumor suppressors facilitates glioblastoma progression"", ""Sensitivity to chromatin structure-targeted therapies""]"
09_Proliferative_2_run2,9,Proliferative 2,09_Proliferative_2,2,0,DNA Replication Licensing and Progression,"A large subset of input genes coordinate replication origin licensing, replication fork progression, DNA synthesis, and chromatin assembly in glioblastoma. Overexpression of licensing factors (MCMs, CDC45, GINS1, MCM10, WDHD1, POLA1/2, POLE2, PRIM2, RRM2, LIG1, ASF1B, CHAF1A/B) accelerates S-phase entry and increases replication fork speed. These changes support unchecked proliferation in glioblastoma, often at the cost of increased replication stress, genomic instability, and therapeutic resistance.","[""MCM6"", ""MCM10"", ""CDC45"", ""GINS1"", ""WDHD1"", ""POLE2"", ""POLA1"", ""POLA2"", ""LIG1"", ""CHAF1A"", ""CHAF1B"", ""ASF1B"", ""PCNA"", ""RRM2""]",14,0.95,"[""Accelerated S-phase entry and DNA replication"", ""Increased replication stress and genome instability"", ""Support for high proliferation rate in malignant glioblastoma""]"
09_Proliferative_2_run2,9,Proliferative 2,09_Proliferative_2,2,1,Homologous Recombination and DNA Damage Response,"Coordinated function of FANCD2, FANCA, FANCI, RAD51AP1, RAD54L, XRCC2, BRCA1, BRCA2, EXO1, BRIP1, RAD18 and CHEK1 supports double-strand break repair via homologous recombination and Fanconi anemia pathway, contributing to DNA repair proficiency and chemo- and radioresistance in GBM. These programs enable DNA repair of oncogene-induced damage from rapid proliferation, protecting viability while reinforcing treatment resistance.","[""FANCD2"", ""FANCA"", ""FANCI"", ""RAD51AP1"", ""RAD54L"", ""XRCC2"", ""BRCA1"", ""BRCA2"", ""EXO1"", ""BRIP1"", ""RAD18"", ""CHEK1"", ""CLSPN""]",13,0.9,"[""Enhanced DNA repair and tolerance to replication stress"", ""Increased resistance to genotoxic chemotherapy and radiotherapy"", ""Maintenance of genomic integrity under oncogenic stress""]"
09_Proliferative_2_run2,9,Proliferative 2,09_Proliferative_2,2,2,Mitotic Regulation and Chromosome Segregation,"Aurora B kinase, PLK4, ESPL1, KIF15, KIF24, SPC24, SPC25, CENPU, CENPI, CENPK, CENPP, SKA3, KNTC1, AURKB, VRK1 coordinate mitotic spindle assembly, kinetochore formation, chromosome alignment, separation and cytokinesis in glioblastoma. Overexpression or mutation of these mitosis regulators is common in high-grade glioma, contributing to polyploidy/aneuploidy, rapid cell cycling, and treatment resistance.","[""MASTL"", ""CENPU"", ""CENPK"", ""CENPI"", ""CENPP"", ""SPC24"", ""SPC25"", ""KNTC1"", ""SKA3"", ""KIF15"", ""KIF24"", ""AURKB"", ""PLK4"", ""VRK1""]",14,0.88,"[""Promotion of cell division and rapid proliferation"", ""Chromosomal instability and increased aneuploidy"", ""Resistance to spindle targeting therapeutics""]"
09_Proliferative_2_run2,9,Proliferative 2,09_Proliferative_2,2,3,Cell Cycle Transcriptional Regulation,"E2F family (E2F1, E2F7), FOXM1, MYBL2 (B-MYB), CCNE2, TCF19, PBK, and related genes form a transcriptional program that activates entry into S-phase and G2/M progression in glioblastoma. They coordinate expression of DNA replication, mitosis, and checkpoint genes and mediate adaptation to oncogenic signals. FOXM1 and E2Fs drive cell cycle gene expression and promote proliferation, invasion, stemness, and drug resistance in GBM.","[""E2F1"", ""FOXM1"", ""E2F7"", ""MYBL2"", ""CCNE2"", ""PBK"", ""TCF19""]",7,0.93,"[""Upregulated expression of replication and mitosis genes"", ""Enhanced proliferation and treatment resistance"", ""Increased invasion, stemness, and poor prognosis""]"
09_Proliferative_2_run2,9,Proliferative 2,09_Proliferative_2,2,4,Epigenetic Regulation and Chromatin Remodeling,"UHRF1, HELLS, ATAD2, ASF1B, CHAF1A/CHAF1B, MNBL3, DNA2 and others participate in chromatin remodeling, DNA methylation, and histone modification in glioblastoma. These processes regulate gene expression, facilitate cell cycle progression, and contribute to treatment resistance and cellular adaptation.","[""UHRF1"", ""HELLS"", ""ATAD2"", ""ASF1B"", ""CHAF1A"", ""CHAF1B""]",6,0.89,"[""Epigenetic silencing of tumor suppressors and altered gene expression"", ""Increased proliferation and resistance to therapy"", ""Enhanced adaptability and stemness in glioblastoma""]"
10_AC-gliosis-like_2_run1,10,AC-gliosis-like 2,10_AC-gliosis-like_2,1,0,Mesenchymal Invasion & EMT,"Genes such as POSTN, HMGA2, ITGA3, SERPINE1, EMP1, ANXA2 drive extracellular matrix remodeling, loss of adhesion, invasion and mesenchymal transition in glioblastoma. POSTN/EMP1/ANXA2 anchor mesenchymal subtypes and promote integrin-mediated invasion. HMGA2 supports EMT transcriptional programs. SERPINE1 enhances invasion and correlates with poor-prognosis, acting together with EMT and migration genes.","[""POSTN"", ""HMGA2"", ""SERPINE1"", ""ITGA3"", ""EMP1"", ""ANXA2""]",6,1.0,"[""increased invasion and migration"", ""promotion of mesenchymal phenotype"", ""therapy resistance due to enhanced motility""]"
10_AC-gliosis-like_2_run1,10,AC-gliosis-like 2,10_AC-gliosis-like_2,1,1,Stemness & WNT-Driven Maintenance,"LEF1, WNT16, and HMGA2 are central to maintaining glioblastoma stemness and proliferation through canonical and non-canonical WNT pathways. LEF1 is a transcriptional mediator of WNT signaling, required for stem cell traits and proliferation.","[""LEF1"", ""WNT16"", ""HMGA2""]",3,0.95,"[""increased self-renewal of tumor stem cells"", ""enhanced tumor proliferation and resistance""]"
10_AC-gliosis-like_2_run1,10,AC-gliosis-like 2,10_AC-gliosis-like_2,1,2,Angiogenesis & Microenvironment Interaction,"ANGPT1, ALK, PDGFD, POSTN, COL22A1, COL23A1, COL25A1, COL27A1 and ANXA2, TMEM154 drive angiogenic and microenvironmental cues in glioblastoma. VEGFA-independent mechanisms are engaged by ANGPT1, POSTN and PDGFD.","[""ANGPT1"", ""PDGFD"", ""POSTN"", ""COL22A1"", ""COL23A1"", ""COL25A1"", ""COL27A1"", ""ANXA2"", ""TMEM154""]",9,0.9,"[""promoted tumor vascularization"", ""microenvironment remodeling"", ""increased resistance to anti-angiogenic therapies""]"
10_AC-gliosis-like_2_run1,10,AC-gliosis-like 2,10_AC-gliosis-like_2,1,3,Neuronal-Synaptic & Neurotransmitter Modulation,"Genes such as GRM7, GABBR2, SLC18A1, NTSR1, CAMK2A/2B, and RGS20 modulate neurotransmitter signaling, neuron-glia synaptic interaction, and excitatory/inhibitory balance in glioblastoma. AMPA and GABAergic interactions enable bidirectional synaptic communication influencing proliferation and invasion.","[""GRM7"", ""GABBR2"", ""CAMK2A"", ""CAMK2B"", ""SLC18A1"", ""NTSR1"", ""RGS20""]",7,0.88,"[""increased responsiveness to neuronal activity"", ""modulation of proliferation and invasion via synaptic transmission""]"
10_AC-gliosis-like_2_run1,10,AC-gliosis-like 2,10_AC-gliosis-like_2,1,4,Hypoxia/Metabolic Stress Adaptation,"Genes such as CA2, GDF15, EGR1, TRIB3, RCAN1, and SLC4A4 modulate metabolic adaptation to hypoxia and cellular stress. Carbonic anhydrases and GDF15 regulate pH and apoptosis, EGR1 controls hypoxic gene expression. TRIB3 and RCAN1 contribute to autophagic and stress resistance.","[""CA2"", ""GDF15"", ""EGR1"", ""TRIB3"", ""RCAN1"", ""SLC4A4""]",6,0.83,"[""enhanced cell survival under hypoxia"", ""increased resistance to metabolic stress and therapeutic intervention""]"
10_AC-gliosis-like_2_run2,10,AC-gliosis-like 2,10_AC-gliosis-like_2,2,0,Invasion and Migration Signaling,"Regulated by POSTN, HMGA2, SERPINE1, ANXA2, TRPM8, SPRY proteins (SPRY1/2/4), ITGA3, and EGR1, whose combined roles drive the invasive phenotype in glioblastoma via extracellular matrix remodeling, epithelial-mesenchymal transition, and enhancement of migration machinery. POSTN, SERPINE1, HMGA2, ANXA2, and ITGA3 collaboratively underpin key steps of invasion; TRPM8 and EGR1 also contribute through regulation of intracellular signaling and adhesion; SPRY genes function as modulators of RTK signaling and EMT.","[""POSTN"", ""SERPINE1"", ""HMGA2"", ""ITGA3"", ""ANXA2"", ""FHL2"", ""SPRY1"", ""SPRY2"", ""SPRY4"", ""EGR1""]",10,0.98,"[""Enhanced extracellular matrix degradation and remodeling"", ""Upregulated EMT-driven cell migration"", ""Increased tissue invasion and therapy resistance""]"
10_AC-gliosis-like_2_run2,10,AC-gliosis-like 2,10_AC-gliosis-like_2,2,1,Angiogenesis and Neovascularization,"ANGPT1, VEGFA-pathway genes, POSTN, FHL2, GDF15, ALK, and EPHA3 contribute to pro-angiogenic programs in malignant glioblastoma, facilitating abnormal vessel formation and maintenance. GDF15 and POSTN secreted by tumor or stromal cells stimulate proliferation, survival, and promote neovascularization in hypoxic tumor regions. ALK and EPHA3 pathways enhance vessel stability and tumor expansion via paracrine and autocrine signaling.","[""ANGPT1"", ""POSTN"", ""FHL2"", ""ALK"", ""GDF15"", ""EPHA3""]",6,0.94,"[""Accelerated neovascularization in hypoxic tumor regions"", ""Enhanced vessel permeability and stability"", ""Therapy resistance due to abnormal vascular architecture""]"
10_AC-gliosis-like_2_run2,10,AC-gliosis-like 2,10_AC-gliosis-like_2,2,2,WNT/Stemness Signaling,"LEF1, WNT16, SPRY, FHL2, and HOPX, with supporting lncRNA and homeodomain regulators, interact to promote WNT pathway activation, stem-cell maintenance, and tumor propagation. LEF1 and WNT pathway genes drive self-renewal capability and resistance, particularly in stem-like and mesenchymal GBM. FHL2 further activates Î²-catenin/WNT signaling.","[""LEF1"", ""WNT16"", ""FHL2"", ""SPRY2"", ""HOPX""]",5,0.9,"[""Promotion of glioblastoma stem cell self-renewal"", ""Enhanced therapy resistance"", ""Propagation of heterogeneity and tumor growth""]"
11_OPC-like_1_run1,11,OPC-like 1,11_OPC-like_1,1,0,Cell Migration and Invasion,"Encompasses activation of cytoskeletal dynamics, ECM remodeling, and integrin/adhesion signaling via upregulation of AFAP1L2, FERMT1, ELMO1, COL4A3/COL4A4, ITGA9, TNS3, ALCAM, PRSS12, and focal adhesion/cytoskeletal regulators. These support aggressive migratory and invasive behaviors fundamental to malignant glioblastoma cells.","[""AFAP1L2"", ""FERMT1"", ""TNS3"", ""ITGA9"", ""COL4A3"", ""COL4A4"", ""ELMO1"", ""PRSS12"", ""ALCAM"", ""PODN""]",10,0.98,"[""Enhanced cytoskeletal dynamics and adhesion-dependent migration"", ""Accelerated ECM breakdown facilitating invasion"", ""Upregulated integrin and focal adhesion machinery driving motility""]"
11_OPC-like_1_run1,11,OPC-like 1,11_OPC-like_1,1,1,Oligodendrocyte/Stem-like Myelination Program,"Includes key drivers of myelin gene expression, oligodendrocyte precursor function, and glioma stemnessâ€”BCAS1, MYRF, SOX6, UGT8, CLDN11, FA2Hâ€”often hijacked by glioblastoma to fuel growth, plasticity, and stem cell-like properties.","[""BCAS1"", ""MYRF"", ""SOX6"", ""UGT8"", ""CLDN11"", ""FA2H""]",6,0.92,"[""Enhanced lineage plasticity and stem-like features"", ""Upregulation of myelin gene expression enables tumor adaptability"", ""Supports aggressive proliferation and potential resistance to therapy""]"
11_OPC-like_1_run1,11,OPC-like 1,11_OPC-like_1,1,2,"Calcium, Ion Channel, and Synaptic Pathway","Multiple input genes encode voltage-gated calcium channels, synaptic receptor subunits, and ion channel regulators (CACNA1E, TRPC4, ANO3, GSG1L, SLC8A3, KCNIP3, AQP4). These orchestrate dysregulated ionic homeostasis, drive excitatory signaling, and enable tumor proliferation, migration, and neuro-glial network hijacking.","[""CACNA1E"", ""TRPC4"", ""SLC8A3"", ""KCNIP3"", ""GSG1L"", ""ANO3"", ""AQP4"", ""UGT8""]",8,0.87,"[""Promotes dysregulated migration, proliferation, and network formation"", ""Amplifies survival via altered calcium signaling"", ""Enhances invasive behavior through aquaporin regulation""]"
11_OPC-like_1_run1,11,OPC-like 1,11_OPC-like_1,1,3,Angiogenesis and Vascular Remodeling,"Features regulation of angiogenic growth factors, ECM and vessel-related proteins (THSD4, COL4A3, COL4A4, LAMB4, ITGA9, PODN) crucial to neovascularization, blood-brain barrier adaptation, and relapse.","[""THSD4"", ""COL4A3"", ""COL4A4"", ""LAMB4"", ""ITGA9"", ""PODN""]",6,0.86,"[""Promotes vessel formation and aberrant angiogenesis"", ""Facilitates tumor expansion and immune evasion"", ""Enables therapy resistance via vascular remodeling""]"
11_OPC-like_1_run2,11,OPC-like 1,11_OPC-like_1,2,0,Oligodendrocyte Differentiation & Myelin Formation,"This program encompasses genes essential for terminal oligodendrocyte differentiation, myelination gene expression, and mature oligodendrocyte identity. The genes coordinate myelin-specific transcriptional networks critical for CNS myelination and are aberrantly expressed in glioblastoma, potentially reflecting transdifferentiation capacity or tumor-promoting influences from OPCs in the microenvironment.","[""MYRF"", ""SOX6"", ""CLDN11"", ""OMG"", ""MOG"", ""UGT8"", ""BCAS1"", ""FA2H"", ""PLPP4"", ""LRRC7"", ""LRRC3B""]",11,0.92,"[""Enhanced oligodendrocytic differentiation capacity in tumor cells"", ""Transdifferentiation of glioblastoma cells toward oligodendrocyte lineage"", ""Aberrant myelin gene program activation contributing to tumor heterogeneity"", ""Interference with normal OPC function through paracrine signaling""]"
11_OPC-like_1_run2,11,OPC-like 1,11_OPC-like_1,2,1,Extracellular Matrix & Basement Membrane Organization,"Comprehensive ECM remodeling program involving collagen IV chains, adhesion molecules, proteoglycans, and proteases. This program supports tumor invasiveness, vascular permeability, and tissue remodeling characteristic of glioblastoma progression and angiogenesis.","[""COL4A3"", ""COL4A4"", ""COL20A1"", ""LAMB4"", ""ADAMTS17"", ""PAPPA"", ""PRSS12"", ""FERMT1"", ""ITGA9"", ""ALCAM"", ""PCDH15"", ""MDGA2"", ""TNS3"", ""HS6ST2"", ""CHST9""]",15,0.88,"[""Enhanced basement membrane degradation promoting tumor invasiveness"", ""Increased ECM turnover supporting angiogenesis and vascular remodeling"", ""Enhanced integrin signaling promoting glioma cell migration"", ""Altered tissue architecture facilitating perivascular invasion""]"
11_OPC-like_1_run2,11,OPC-like 1,11_OPC-like_1,2,2,Neuregulin-ErbB Receptor Signaling & Growth Promotion,"Ligand-receptor signaling through neuregulin-dependent ErbB activation promoting tumor cell survival, growth, and stemness. ERBB3 is frequently dysregulated in glioblastoma subsets and drives metabolic dependency.","[""ERBB3"", ""VIPR2"", ""CALCRL"", ""FGF12"", ""PDE4A"", ""TRPC4"", ""CACNA1E""]",7,0.78,"[""Enhanced survival through ErbB-PI3K-AKT signaling"", ""Metabolic rewiring dependent on ERBB3 activation"", ""Increased stemness and self-renewal"", ""Resistance to conventional therapies""]"
11_OPC-like_1_run2,11,OPC-like 1,11_OPC-like_1,2,3,Calcium Signaling & Ion Channel Activity,"Coordinated calcium and cation homeostasis regulating neuronal-like excitability, synaptic plasticity, and transcriptional responses critical for glioma cell behavior.","[""CACNA1E"", ""TRPC4"", ""SLC8A3"", ""SLC26A7"", ""KCNIP3"", ""PDE4A"", ""PDE7B"", ""PRKG2"", ""ANO3"", ""ANO4"", ""GSG1L"", ""LRRC7"", ""MDGA2"", ""TACR1""]",14,0.85,"[""Enhanced neuronal-like electrophysiological properties"", ""Calcium-dependent activation of stemness programs"", ""Regulation of glioma cell motility and invasion"", ""Integration into neural circuits""]"
11_OPC-like_1_run2,11,OPC-like 1,11_OPC-like_1,2,4,Cell Cycle Progression & Proliferation Control,"G1/S checkpoint regulation through cyclin-CDK complexes. CCND1 drives G1-S transition, frequently dysregulated in glioblastoma.","[""CCND1"", ""DLL3"", ""DLL1""]",3,0.82,"[""Uncontrolled G1/S progression enabling continuous proliferation"", ""Bypass of retinoblastoma checkpoint"", ""Maintenance of GSC stemness through Notch-DLL signaling"", ""Resistance to differentiation-inducing therapies""]"
11_OPC-like_1_run2,11,OPC-like 1,11_OPC-like_1,2,5,Epithelial-Mesenchymal Transition & Invasion,"EMT-like processes enabling enhanced migratory and invasive phenotypes through altered adhesion, mesenchymal characteristics, and enhanced motility.","[""SLIT1"", ""SEMA3E"", ""ALCAM"", ""PCDH15"", ""TNR"", ""FERMT1"", ""DOCK10"", ""ADAMTS17"", ""TNS3"", ""LRRC3B"", ""LRRC7"", ""BRINP1"", ""DISC1"", ""ITGA9""]",14,0.87,"[""Enhanced migratory capacity enabling infiltrative brain invasion"", ""Increased invasiveness and escape from primary tumor"", ""Therapy-resistant phenotypes through stemness acquisition"", ""Enhanced mechanosensing enabling tissue adaptation""]"
11_OPC-like_1_run2,11,OPC-like 1,11_OPC-like_1,2,6,Lipid Metabolism & Bioenergetics Rewiring,Dysregulated lipid biosynthesis and storage supporting rapid tumor growth. GBM exhibits SREBP-1-driven lipid accumulation.,"[""PLPP4"", ""PLA2G4A"", ""FA2H"", ""GFPT2"", ""UGDH"", ""PLAAT1"", ""UGT8"", ""MYRIP"", ""ATP13A5""]",9,0.84,"[""Rapid cell growth through enhanced membrane synthesis"", ""Ferroptosis resistance through lipid droplet sequestration"", ""Metabolic flexibility and nutritional adaptation"", ""Chemotherapy survival through altered membrane composition""]"
11_OPC-like_1_run2,11,OPC-like 1,11_OPC-like_1,2,7,Hypoxia Response & Angiogenic Signaling,Adaptive responses to hypoxic microenvironment through HIF-1Î± stabilization and pro-angiogenic pathway activation.,"[""CA10"", ""CALCRL"", ""VIPR2"", ""ADAMTS17"", ""GFPT2"", ""UGDH"", ""FGF12"", ""PDE4A"", ""PLPP4""]",9,0.83,"[""Enhanced survival under hypoxic stress"", ""Activation of pro-angiogenic programs"", ""Metabolic flexibility adapting to hypoxia"", ""Increased stemness and therapeutic resistance""]"
11_OPC-like_1_run2,11,OPC-like 1,11_OPC-like_1,2,8,Cancer Stem Cell Maintenance & Plasticity,Self-renewal and multi-lineage differentiation of glioma stem cells. LIN28B maintains developmental plasticity through let-7 miRNA suppression.,"[""SOX6"", ""LIN28B"", ""DLL3"", ""DLL1"", ""EYA1"", ""MIR503HG"", ""MIR217HG"", ""ERBB3"", ""DISC1""]",9,0.86,"[""Unlimited self-renewal enabling tumor re-initiation"", ""Multi-lineage differentiation potential"", ""Resistance to differentiation-based therapies"", ""Phenotypic plasticity enabling microenvironmental adaptation""]"
11_OPC-like_1_run2,11,OPC-like 1,11_OPC-like_1,2,9,Long Non-Coding RNA Regulatory Networks,"lncRNA-mediated gene regulation affecting GBM progression, therapy resistance, and cellular plasticity.","[""LINC00689"", ""LINC01268"", ""LINC01322"", ""LINC00320"", ""MIR503HG"", ""MIR217HG"", ""FRG1-DT"", ""AC110285.1"", ""AC023282.1"", ""AC068308.1"", ""AC077690.1"", ""AL031293.1"", ""AC104051.2"", ""AL139231.1"", ""AL136114.1"", ""AC005909.2"", ""AL512308.1"", ""C2orf27A"", ""LHFPL3-AS1""]",19,0.76,"[""Fine-tuning of oncogenic pathway activation"", ""Enhanced multidrug resistance"", ""Altered differentiation and stemness"", ""Tumor-promoting transcriptional programs""]"
12_NPC-neuronal-like_3_run1,12,NPC-neuronal-like 3,12_NPC-neuronal-like_3,1,0,Glutamatergic Signaling & Excitotoxicity,"Includes NMDA receptor signaling (GRIN3A), glutamate transport (SLC17A6), synaptic vesicle cycling (SYT1, SV2B, SYNPR), glutamate release and reuptake, contributing to neural excitability and tumor-associated seizures in glioblastoma.","[""GRIN3A"", ""SLC17A6"", ""SYT1"", ""SV2B"", ""SYNPR""]",5,1.0,"[""Enhanced synaptogenic and excitatory signaling capacity"", ""Increased susceptibility to tumor-associated hyperexcitability and seizures"", ""Augmented resistance to radiotherapy via NMDA-dependent pathways""]"
12_NPC-neuronal-like_3_run1,12,NPC-neuronal-like 3,12_NPC-neuronal-like_3,1,1,GABAergic and Neuronal Differentiation,"Markers and regulators of interneuron fate and synaptic inhibition, including GABA-A receptor subunits (GABRA1, GABRB2), classic interneuron fate determinants (DLX6, ARX, LAMP5), and interneuron differentiation regulators (SRRM4, RBFOX3).","[""GABRA1"", ""GABRB2"", ""DLX6"", ""ARX"", ""SRRM4"", ""RBFOX3"", ""LAMP5""]",7,0.9,"[""Impaired inhibitory synaptic control in glioblastoma microenvironment"", ""Potential for tumor-associated epileptiform activity"", ""Presence of neuron-like gene signatures indicating partial differentiation""]"
12_NPC-neuronal-like_3_run1,12,NPC-neuronal-like 3,12_NPC-neuronal-like_3,1,2,Neural Cell Adhesion & Migration,"Cadherins, contactins, and ephrin/ROBO/SLIT pathway molecules (CDH4, CDH12, CDH18, CNTN2, CNTNAP5, EPHA3, EPHA5, EPHA7, ROBO3, SLIT1, FLRT2, NXPH1, CRIM1) regulate cell adhesion, migration, and axon guidanceâ€”a core mechanism underlying glioblastoma invasiveness.","[""CDH4"", ""CDH12"", ""CDH18"", ""CNTN2"", ""CNTNAP5"", ""EPHA3"", ""EPHA5"", ""EPHA7"", ""ROBO3"", ""SLIT1"", ""FLRT2"", ""NXPH1"", ""CRIM1""]",13,0.95,"[""Augmented glioblastoma migration, infiltration, and invasion"", ""Potential hijacking of axon guidance cues for tumor dispersal""]"
12_NPC-neuronal-like_3_run1,12,NPC-neuronal-like 3,12_NPC-neuronal-like_3,1,3,Calcium Signaling and Ion Homeostasis,"Encompasses genes for calcium channels (CACNA2D3), phospholipase C signaling (PLCB1), potassium channels (KCNQ3, KCNK2, KCNH8), ion cotransporters (SLC4A10), and associated effectors (PRKCA, ADCY8). Core program for proliferation, migration, and apoptosis resistance in glioblastoma.","[""CACNA2D3"", ""PLCB1"", ""KCNQ3"", ""KCNK2"", ""KCNH8"", ""SLC4A10"", ""PRKCA"", ""ADCY8""]",8,0.85,"[""Proliferation, survival, and resistance to apoptosis"", ""Modulation of migration/invasion via ionic signaling""]"
12_NPC-neuronal-like_3_run1,12,NPC-neuronal-like 3,12_NPC-neuronal-like_3,1,4,Transcriptional and Epigenetic Reprogramming,"Transcription factors (MEIS2, ARX, DLX6, EBF3, MYT1L, PBX3, THRB, CUX2, TP73), chromatin remodelers, and splicing regulators (SRRM4, RBFOX3) contribute to cell fate plasticity, maintenance of stemness, and tumor cell adaptation.","[""MEIS2"", ""ARX"", ""DLX6"", ""EBF3"", ""MYT1L"", ""PBX3"", ""THRB"", ""CUX2"", ""TP73"", ""SRRM4"", ""RBFOX3""]",11,0.8,"[""Maintenance of stem cell\u2013like state in subpopulations"", ""Plasticity and resistance to differentiation therapies""]"
12_NPC-neuronal-like_3_run2,12,NPC-neuronal-like 3,12_NPC-neuronal-like_3,2,0,Glutamatergic Signaling & Excitotoxicity,"Includes NMDA receptor signaling (GRIN3A), glutamate transport (SLC17A6), synaptic vesicle cycling (SYT1, SV2B, SYNPR), glutamate release and reuptake, contributing to neural excitability and tumor-associated seizures in glioblastoma.","[""GRIN3A"", ""SLC17A6"", ""SYT1"", ""SV2B"", ""SYNPR""]",5,1.0,"[""Enhanced synaptogenic and excitatory signaling capacity"", ""Increased susceptibility to tumor-associated hyperexcitability and seizures"", ""Augmented resistance to radiotherapy via NMDA-dependent pathways""]"
12_NPC-neuronal-like_3_run2,12,NPC-neuronal-like 3,12_NPC-neuronal-like_3,2,1,GABAergic and Neuronal Differentiation,"Markers and regulators of interneuron fate and synaptic inhibition, including GABA-A receptor subunits (GABRA1, GABRB2), classic interneuron fate determinants (DLX6, ARX, LAMP5), and interneuron differentiation regulators (SRRM4, RBFOX3).","[""GABRA1"", ""GABRB2"", ""DLX6"", ""ARX"", ""SRRM4"", ""RBFOX3"", ""LAMP5""]",7,0.9,"[""Impaired inhibitory synaptic control in glioblastoma microenvironment"", ""Potential for tumor-associated epileptiform activity"", ""Presence of neuron-like gene signatures indicating partial differentiation""]"
12_NPC-neuronal-like_3_run2,12,NPC-neuronal-like 3,12_NPC-neuronal-like_3,2,2,Neural Cell Adhesion & Migration,"Cadherins, contactins, and ephrin/ROBO/SLIT pathway molecules (CDH4, CDH12, CDH18, CNTN2, CNTNAP5, EPHA3, EPHA5, EPHA7, ROBO3, SLIT1, FLRT2, NXPH1, CRIM1) regulate cell adhesion, migration, and axon guidanceâ€”a core mechanism underlying glioblastoma invasiveness.","[""CDH4"", ""CDH12"", ""CDH18"", ""CNTN2"", ""CNTNAP5"", ""EPHA3"", ""EPHA5"", ""EPHA7"", ""ROBO3"", ""SLIT1"", ""FLRT2"", ""NXPH1"", ""CRIM1""]",13,0.95,"[""Augmented glioblastoma migration, infiltration, and invasion"", ""Potential hijacking of axon guidance cues for tumor dispersal""]"
12_NPC-neuronal-like_3_run2,12,NPC-neuronal-like 3,12_NPC-neuronal-like_3,2,3,Calcium Signaling and Ion Homeostasis,"Encompasses genes for calcium channels (CACNA2D3), phospholipase C signaling (PLCB1), potassium channels (KCNQ3, KCNK2, KCNH8), ion cotransporters (SLC4A10), and associated effectors (PRKCA, ADCY8). Core program for proliferation, migration, and apoptosis resistance in glioblastoma.","[""CACNA2D3"", ""PLCB1"", ""KCNQ3"", ""KCNK2"", ""KCNH8"", ""SLC4A10"", ""PRKCA"", ""ADCY8""]",8,0.85,"[""Proliferation, survival, and resistance to apoptosis"", ""Modulation of migration/invasion via ionic signaling""]"
12_NPC-neuronal-like_3_run2,12,NPC-neuronal-like 3,12_NPC-neuronal-like_3,2,4,Transcriptional and Epigenetic Reprogramming,"Transcription factors (MEIS2, ARX, DLX6, EBF3, MYT1L, PBX3, THRB, CUX2, TP73), chromatin remodelers, and splicing regulators (SRRM4, RBFOX3) contribute to cell fate plasticity, maintenance of stemness, and tumor cell adaptation.","[""MEIS2"", ""ARX"", ""DLX6"", ""EBF3"", ""MYT1L"", ""PBX3"", ""THRB"", ""CUX2"", ""TP73"", ""SRRM4"", ""RBFOX3""]",11,0.8,"[""Maintenance of stem cell\u2013like state in subpopulations"", ""Plasticity and resistance to differentiation therapies""]"
13_OPC-like_2_run1,13,OPC-like 2,13_OPC-like_2,1,0,Oligodendrocyte myelin transcriptional control,"Core transcriptional control network directing oligodendrocyte differentiation and myelin gene expression, driven by master regulators SOX10, MYRF, and MYT1L that cooperatively activate myelination program genes","[""SOX10"", ""MYRF"", ""MYT1L"", ""MBP"", ""PLP1"", ""MAG"", ""MOG"", ""CLDN11"", ""NFASC"", ""FA2H"", ""UGT8"", ""EBF2"", ""KCNS3"", ""GLRA3""]",14,0.92,"[""Enhanced myelin formation capacity despite tumor context"", ""Increased oligodendrocyte-specific gene expression signature"", ""Dysregulated coupling of neural activity to myelination programs"", ""Aberrant cell-autonomous myelination trajectory in tumor cells"", ""Preserved ability to respond to oligodendroglial differentiation signals""]"
13_OPC-like_2_run1,13,OPC-like 2,13_OPC-like_2,1,1,Myelin lipid synthesis and homeostasis,"Coordinated lipid metabolic pathway for synthesis and maintenance of specialized myelin lipids including galactocerebroside, sulfatide, and 2-hydroxylated sphingolipids essential for myelin structure and function","[""FA2H"", ""UGT8"", ""CHST15"", ""UST"", ""ABCA2""]",5,0.78,"[""Modified lipid composition affecting myelin integrity in tumor microenvironment"", ""Altered membrane properties affecting drug permeability and resistance"", ""Dysregulated cholesterol homeostasis potentially supporting tumor metabolic demands"", ""Aberrant lipid signaling through modified sphingolipids""]"
13_OPC-like_2_run1,13,OPC-like 2,13_OPC-like_2,1,2,ECM proteolysis and glioma invasion,"Coordinated extracellular matrix remodeling through metalloprotease activity, adhesion molecule regulation, and proteoglycan modification that facilitates glioma cell migration and invasion through brain parenchyma","[""ADAM33"", ""ADAMTSL1"", ""ADAMTS14"", ""MMP17"", ""COL18A1"", ""COL20A1"", ""COL12A1"", ""ACAN"", ""GPC3"", ""ITGB5"", ""FERMT1"", ""LIMS2"", ""TNS2"", ""TNS3"", ""CADM1""]",15,0.85,"[""Enhanced ECM degradation promoting glioma cell migration through white matter"", ""Increased invasive capacity through peritumoral brain regions"", ""Altered tumor border architecture through selective ECM remodeling"", ""Aberrant cell-ECM signaling promoting mesenchymal features"", ""Impaired normal ECM-mediated plasticity barriers""]"
13_OPC-like_2_run2,13,OPC-like 2,13_OPC-like_2,2,0,Oligodendrocyte Lineage Programming,"Coordinated expression of factors driving oligodendrocyte differentiation and myelin formation, hijacked by glioblastoma cells to promote stemness and infiltration. This program involves master transcription factors (SOX10, MYRF, EBF2) that orchestrate the expression of myelin structural proteins (MBP, MOG, PLP1, UGT8), lipid biosynthesis enzymes, and adhesion molecules characteristic of oligodendrocyte lineage cells.","[""SOX10"", ""MYRF"", ""EBF2"", ""MBP"", ""MOG"", ""PLP1"", ""UGT8"", ""FA2H"", ""CLDN11"", ""NFASC"", ""PRDM16"", ""BCAS1""]",12,0.92,"[""Enhanced stemness and self-renewal through hijacking of normal OPC developmental programs"", ""Increased infiltration capacity through expression of oligodendrocyte-like migratory behavior"", ""Immune evasion via expression of OPC-associated immune-suppressive markers"", ""Enhanced invasion at tumor margins where OPC-like features promote white matter infiltration""]"
13_OPC-like_2_run2,13,OPC-like 2,13_OPC-like_2,2,1,Extracellular Matrix Remodeling and Invasion,"Coordinated expression of matrix metalloproteases, their inhibitors, collagen synthesis, and proteoglycan biosynthesis driving ECM degradation and tumor cell migration. This program enables breach of white matter boundaries and tumor infiltration through mechanistic regulation of matrix stiffness and integrin-mediated adhesion.","[""MMP17"", ""ADAMTS14"", ""ADAM33"", ""COL18A1"", ""COL20A1"", ""COL12A1"", ""ACAN"", ""GPC3"", ""ITGB5"", ""FERMT1"", ""TNS3"", ""TNS2"", ""PRSS12"", ""TLL1"", ""CHST15""]",15,0.88,"[""Enhanced invasive capacity through ECM proteolysis and remodeling"", ""Increased migration velocity and directional movement via altered matrix stiffness"", ""Enhanced cell-ECM interactions promoting tumor cell survival in invaded tissue"", ""Facilitated angiogenesis through matrix-derived proangiogenic signals""]"
13_OPC-like_2_run2,13,OPC-like 2,13_OPC-like_2,2,2,Neuron-to-Tumor Synaptic Integration,"Expression of synaptic proteins, calcium-permeable ion channels, and neurotransmitter machinery enabling glioblastoma cells to receive excitatory input from neurons and engage synaptic signaling for proliferation and invasion. This program converts tumor cells into post-synaptic partners that co-opt neuronal circuits for survival.","[""SYT6"", ""SYT7"", ""SHANK2"", ""NFASC"", ""CADM1"", ""SLC1A1"", ""ITPR2"", ""P2RX7"", ""P2RX4"", ""KCNS3"", ""ANO3"", ""GLRA3"", ""GPR17"", ""NOS1"", ""SEMA4D""]",15,0.87,"[""Enhanced survival and proliferation through neuron-derived glutamate signaling"", ""Calcium-dependent activation of pro-growth signaling cascades (PI3K/Akt, MAPK/ERK)"", ""Increased migration capacity through AMPA-integrin coupling"", ""Improved therapy resistance via neuronal neuroprotective signals"", ""Enhanced infiltration along neuronal projections and white matter tracts""]"
13_OPC-like_2_run2,13,OPC-like 2,13_OPC-like_2,2,3,Axon Guidance and Migratory Reprogramming,"Expression of semaphorins, axon guidance molecules, and associated receptors that repurpose developmental axon guidance signaling to direct glioblastoma cell migration. This program enables tumor cells to follow white matter tracts and perivascular spaces via neuropilin and plexin signaling.","[""SEMA4D"", ""SEMA3D"", ""SEMA3E"", ""DOCK6""]",4,0.72,"[""Directed migration along white matter tracts containing axons"", ""Enhanced infiltration capacity through repurposing of developmental guidance signals"", ""Facilitated perivascular migration through semaphorin signaling"", ""Reduced proliferation in favor of migration phenotype""]"
13_OPC-like_2_run2,13,OPC-like 2,13_OPC-like_2,2,4,Neural Stem Cell Maintenance and Pluripotency,"Expression of transcription factors and signaling molecules that maintain glioblastoma stem cell identity and self-renewal through hijacking of neural progenitor cell developmental programs, including Notch, Wnt, and growth factor signaling.","[""DLL3"", ""PRDM16"", ""PRDM8"", ""EBF2"", ""ERBB3"", ""AATK"", ""ARPP21"", ""MYT1L""]",8,0.8,"[""Enhanced self-renewal and maintenance of glioblastoma stem cells"", ""Resistance to differentiation signals and therapy-induced differentiation"", ""Sustained expression of proliferation and anti-apoptotic pathways"", ""Increased tumor initiation and recurrence capacity""]"
13_OPC-like_2_run2,13,OPC-like 2,13_OPC-like_2,2,5,Cell Cycle Proliferation and Checkpoint Dysregulation,"Coordinated dysregulation of cell cycle checkpoint machinery and cyclin-dependent kinase signaling enabling uncontrolled proliferation, reduced apoptosis, and therapy resistance. This program includes genes regulating G1/S and G2/M transitions, mitotic progression, and apoptotic inhibition.","[""CDK18"", ""TRIM67"", ""CABLES1"", ""TUBB4A"", ""DNAH10"", ""SERPINB9"", ""TFEB"", ""ZNF536""]",8,0.78,"[""Increased proliferation rate and reduced doubling time"", ""Evasion of G1/S and G2/M checkpoints allowing damaged DNA progression"", ""Resistance to apoptosis-inducing stimuli including radiation and chemotherapy"", ""Therapy resistance through continued proliferation despite treatment""]"
13_OPC-like_2_run2,13,OPC-like 2,13_OPC-like_2,2,6,Lipid Metabolism and Membrane Remodeling,"Coordinated expression of lipid biosynthesis, remodeling, and transport machinery enabling enhanced membrane synthesis for tumor growth, vesicular trafficking for invasion, and lipid-dependent signaling. This program supports the massive membrane expansion required for glioblastoma proliferation and the formation of tumor microtubes.","[""UGT8"", ""FA2H"", ""CHST15"", ""PLD1"", ""PLAAT1"", ""ATP8A2"", ""SPNS2"", ""TMEM235"", ""SYT6"", ""SYT7"", ""ABCA2"", ""SLC8A3""]",12,0.73,"[""Increased membrane synthesis supporting rapid tumor growth"", ""Enhanced vesicular trafficking enabling distant cell-cell communication"", ""Promotion of tumor microarchitecture via exosome/microvesicle secretion"", ""Activation of lipid-dependent signaling (PLD/PKC, PI3K, DAG-dependent kinases)""]"
13_OPC-like_2_run2,13,OPC-like 2,13_OPC-like_2,2,7,Hypoxia Response and Angiogenic Signaling,"Expression of HIF-1alpha target genes and hypoxia-adaptive factors enabling glioblastoma survival under oxygen deprivation, promotion of neovascularization, and metabolic reprogramming. This program is activated in hypoxic tumor core and contributes to therapy resistance and immunosuppression.","[""TF"", ""CA10"", ""DIO2"", ""PTGDS"", ""FGF12"", ""BMP2"", ""BMPER""]",7,0.75,"[""Survival and proliferation under hypoxic stress in tumor core"", ""Enhanced angiogenesis and vascularization"", ""Shift to glycolytic metabolism supporting rapid ATP generation"", ""Increased immunosuppression through HIF-dependent immune modulation"", ""Therapy resistance through upregulation of drug efflux and DNA repair""]"
13_OPC-like_2_run2,13,OPC-like 2,13_OPC-like_2,2,8,Autophagy and Lysosomal Degradation,"Coordinated expression of autophagy machinery and lysosomal degradation genes enabling glioblastoma cells to survive metabolic stress, nutrient deprivation, and chemotherapy through enhanced cellular self-digestion and recycling.","[""TFEB"", ""ATP6V0A4"", ""CABLES1"", ""TMEM235""]",4,0.77,"[""Enhanced survival during glucose/nutrient starvation"", ""Chemotherapy resistance through selective degradation of drug-induced damage"", ""Maintenance of cellular homeostasis under hypoxic stress"", ""Possible shift from autophagic survival to autophagic cell death depending on context""]"
13_OPC-like_2_run2,13,OPC-like 2,13_OPC-like_2,2,9,Amino Acid Metabolism and Nutrient Transport,"Expression of amino acid transporters and metabolic enzymes enabling glioblastoma cells to sustain glutaminolysis, maintain nucleotide synthesis, and adapt to the nutrient-scarce tumor microenvironment through reprogrammed amino acid metabolism.","[""SLC7A14"", ""SLC1A1"", ""SLC8A3"", ""AMPD3"", ""CPM"", ""CNDP1""]",6,0.74,"[""Enhanced glutamine uptake and catabolism supporting TCA cycle and biosynthesis"", ""Metabolic flexibility enabling adaptation to nutrient scarcity"", ""Increased amino acid-derived ATP production"", ""Reprogrammed amino acid metabolism contributing to immunosuppressive microenvironment""]"
13_OPC-like_2_run2,13,OPC-like 2,13_OPC-like_2,2,10,DNA Damage Response and Genomic Stability,"Expression of DNA damage sensing, checkpoint control, and repair machinery enabling glioblastoma cells to tolerate the genomic alterations underlying their malignancy and resist therapy-induced DNA damage.","[""CABLES1"", ""ZNF536"", ""SIRT2""]",3,0.65,"[""Enhanced tolerance for genomic mutations underlying malignancy"", ""Radiotherapy resistance through rapid DNA repair"", ""Chemotherapy resistance through checkpoint activation and drug efflux"", ""Tumor evolution and acquisition of additional oncogenic mutations""]"
